TARGET USI	Mixture	Gender	Race	Ethnicity	Age at Diagnosis in Days	First Event	Event Free Survival Time in Days	Vital Status	Overall Survival Time in Days	Year of Diagnosis	Year of Last Follow Up	Protocol	WBC at Diagnosis	Bone marrow leukemic blast percentage (%)	Peripheral blasts (%)	CNS disease	Chloroma	FAB Category	t(6;9)	t(8;21)	t(3;5)(q25;q34)	t(6;11)(q27;q23)	t(9;11)(p22;q23)	t(10;11)(p11.2;q23)	t(11:19)(q23:p13.1)	inv(16)	del5q	del7q	del9q	monosomy 5	monosomy 7	trisomy 8	trisomy 21	MLL	Minus Y	Minus X	Cytogenetic Code Other	Cytogenetic Complexity	Primary Cytogenetic Code	ISCN	FLT3/ITD positive?	FLT3/ITD allelic ratio	FLT3 PM	NPM mutation	CEBPA mutation	WT1 mutation	c-Kit Mutation Exon 8	c-Kit Mutation Exon 17	MRD at end of course 1	MRD % at end of course 1	MRD at end of course 2	MRD % at end of course 2	CR status at end of course 1	CR status at end of course 2	Risk group	SCT in 1st CR	Bone Marrow Site of Relapse/Induction Failure	CNS Site of Relapse/Induction Failure	Chloroma Site of Relapse/Induction Failure	Cytogenetic Site of Relapse/Induction Failure	Other Site of Relapse/Induction Failure	Gene Fusion	Gemtuzumab ozogamicin treatment	Refractory Timepoint sent for Induction Failure Project	Comment
PABGKN	TARGET-20-PABGKN-09A-01R	Female	White	Not Hispanic or Latino	6641	Death without Remission	95	Dead	95	1998	1998	CCG-2961	32.9	71	86	Yes	Yes	M2	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	 	NA	Unknown	Unknown	Yes	0.18	No	No	No	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	Death	Unknown	No	Not done	Not done	Not done	Not done	Not done	NA		EOI II	"Discovery,Validation"
PABHET	TARGET-20-PABHET-03A-02R	Female	White	Not Hispanic or Latino	5368	Censored	3632	Alive	3632	1998	2008	CCG-2961	7.3	63	64	No	No	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	t(8;21)	"46,XX,t(8:21)(q22:q22)[15]"	No	NA	No	No	No	Yes	No	No	Unknown	NA	Unknown	NA	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	RUNX1-RUNX1T1			"This case is also found in the AML validation clinical data for frequency testing (TCS) - Induction Failure,Validation,TMA"
PABHKY	TARGET-20-PABHKY-03A-02R	Female	Black or African American	Not Hispanic or Latino	4698	Censored	2472	Alive	2472	1998	2004	CCG-2961	17.7	68	63	No	No	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	t(8;21)	"46,XX,t(8:21)(q22:q22)[20]"	No	NA	No	No	No	No	No	No	Unknown	NA	Unknown	NA	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	RUNX1-RUNX1T1			"This is an AML-IF (induction failure) case that is also included in the AML discovery clinical data, as  'TARGET-21-PATJMY' - Induction Failure,Validation,TMA"
PABLDZ	TARGET-20-PABLDZ-09A-04R	Female	White	Not Hispanic or Latino	2455	Relapse	714	Alive	721	1997	1999	CCG-2961	6	93	0	No	No	M4	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	 	0	Unknown	G	Yes	0.82	No	No	No	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	High	No	Yes	No	No	No	No	NA			"Discovery,Validation"
PACDZR	TARGET-20-PACDZR-09A-02R	Female	White	Not Hispanic or Latino	1661	Relapse	377	Dead	455	1998	1999	CCG-2961	59	67	85	No	No	M1	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XX[30]"	No	NA	No	No	Yes	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	Low	No	Yes	No	No	No	No	NA			"This case is also found in the AML validation clinical data for frequency testing (TCS) - Induction Failure,Validation"
PADDXZ	TARGET-20-PADDXZ-03A-02R	Male	Black or African American	Not Hispanic or Latino	4861	Relapse	320	Alive	752	1998	2000	CCG-2961	8.1	52	59	No	No	M2	No	Yes	No	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	 	2	t(8;21)	"46,XY,t(8:21)(q22:q22),del(9)(q13q22)[22]"	No	NA	No	No	No	No	No	No	Unknown	NA	Unknown	NA	CR	CR	Low	No	Yes	No	No	No	No	RUNX1-RUNX1T1			"This is an AML-IF (induction failure) case that is also included in the AML discovery clinical data, as  'TARGET-21-PATKBK' - Induction Failure,Validation"
PADYIR	TARGET-20-PADYIR-09A-01R	Male	White	Not Hispanic or Latino	1159	Relapse	373	Dead	585	1996	1998	CCG-2961	13.1	29	11	No	No	M2	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	 	NA	Unknown	Unknown	No	NA	No	No	No	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	Unknown	Yes	Yes	No	No	No	No	NUP98-NSD1			"Discovery,Validation"
PADZCG	TARGET-20-PADZCG-09A-02R	Female	Unknown	Not Hispanic or Latino	5325	Relapse	314	Dead	536	1996	1998	CCG-2961	29.3	58	5	No	No	M4	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XX[20]"	No	NA	No	No	No	No	Not done	Not done	Unknown	NA	Unknown	NA	Not in CR	CR	Standard	No	Yes	No	No	No	No	NA			"Discovery,Validation"
PADZKD	TARGET-20-PADZKD-09A-02R	Female	Black or African American	Not Hispanic or Latino	4887	Relapse	385	Alive	1346	1996	2000	CCG-2961	40.2	56	61	No	No	M1	No	No	No	No	No	Yes	No	Yes	No	No	No	No	No	No	No	Yes	No	No	 	3	inv(16)	"46,XX,inv(16)(p13q22)[23]/46,idem,der(10)t(10:11)(p15:q12)[9]/46,idem,t(6:17)(p25:q21)[7]"	No	NA	No	No	No	Yes	No	No	Unknown	NA	Unknown	NA	CR	CR	Low	No	Yes	No	No	No	Yes	CBFB-MYH11			"This case is also found in the AML validation clinical data for frequency testing (TCS) - Induction Failure,Validation,TMA"
PAEAFC	TARGET-20-PAEAFC-09A-03R	Male	White	Not Hispanic or Latino	5108	Death without Remission	2	Dead	2	1997	1997	CCG-2961	173	88	66	Yes	No	M4	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[20]"	Yes	0.4	No	No	No	Yes	Not done	Not done	Unknown	NA	Unknown	NA	Death	Death	Standard	No	Not done	Not done	Not done	Not done	Not done	NUP98-NSD1			"This is an AML-IF (induction failure) case that is also included in the AML discovery clinical data, as  'TARGET-21-PATKKJ' - Induction Failure,Validation,TMA"
PAEAKL	TARGET-20-PAEAKL-09A-03R	Female	Black or African American	Not Hispanic or Latino	5218	Relapse	134	Dead	163	1997	1997	CCG-2961	96.1	80	81	Yes	No	M5	No	No	No	No	Yes	No	Yes	No	No	No	No	No	No	No	No	Yes	No	No	 	1	MLL	"46,XX,t(11:19)(q23:p13.1)[20]"	No	NA	No	No	No	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	Standard	No	No	No	No	No	Yes	KMT2A-ELL			"This case is also found in the AML validation clinical data for frequency testing (TCS) - Induction Failure,Validation"
PAECBZ	TARGET-20-PAECBZ-09A-03R	Female	Unknown	Not Hispanic or Latino	1394	Censored	3117	Alive	3117	1997	2005	CCG-2961	59.8	71	93	No	No	M2	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XX[38]"	No	NA	No	No	Yes	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	NA			"This is an AML-IF (induction failure) case that is also included in the AML discovery clinical data, as  'TARGET-21-PATKWH' - Induction Failure,Validation"
PAECCE	TARGET-20-PAECCE-09A-01R	Male	White	Not Hispanic or Latino	900	Induction Failure	85	Dead	147	1997	1997	CCG-2961	98.3	95	0	No	No	M5	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	 	NA	Unknown	Unknown	No	NA	No	No	No	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	Not in CR	Unknown	No	Yes	No	Yes	No	No	KMT2A-MLLT10			"Discovery,Validation"
PAEENN	TARGET-20-PAEENN-09A-01R	Female	Black or African American	Not Hispanic or Latino	1430	Death without Remission	33	Dead	33	1997	1997	CCG-2961	25.3	46	7	No	Yes	M4	No	No	No	No	No	No	No	Yes	No	Yes	No	No	No	No	No	No	No	No	 	2	inv(16)	"46,XX,del(7)(q32),inv(16)(p13q22)[14]/46,XX[8]"	No	NA	No	No	No	Yes	No	No	Unknown	NA	Unknown	NA	Death	Death	Low	No	Not done	Not done	Not done	Not done	Not done	CBFB-MYH11			Other Genomic Analyses
PAEERJ	TARGET-20-PAEERJ-09A-01R	Female	White	Not Hispanic or Latino	5082	Relapse	259	Dead	373	1997	1998	CCG-2961	71.9	60	41	No	No	M4	No	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	Other	"46,XX,t(3:5)(q23:q33)[19]/46,XX[1]"	Yes	0.55	No	No	No	Yes	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	High	No	Yes	No	No	No	No	NPM1-MLF1			"Discovery,Validation"
PAEEYP	TARGET-20-PAEEYP-09A-02R	Female	White	Not Hispanic or Latino	567	Induction Failure	100	Dead	398	1997	1998	CCG-2961	165	91	89	No	No	M5	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	Other	"46,XX,del(10)(p13)[30]"	No	NA	No	No	No	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	Not in CR	Standard	No	No	Yes	No	No	No	NA			Other Genomic Analyses
PAEFGR	TARGET-20-PAEFGR-09A-02R	Female	White	Not Hispanic or Latino	549	Relapse	497	Alive	4022	1997	2008	CCG-2961	51.2	75	41	No	No	M2	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XX,inv(16)(p13q22)[21]/46,XX[1]"	No	NA	No	No	No	No	Yes	No	Unknown	NA	Unknown	NA	CR	CR	Low	No	Yes	Yes	No	No	No	CBFB-MYH11			Other Genomic Analyses
PAEFGT	TARGET-20-PAEFGT-03A-01R	Female	White	Not Hispanic or Latino	5452	Relapse	213	Dead	315	1997	1998	CCG-2961	11.4	100	70	No	No	M2	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	 	0	Unknown	I	Yes	0.83	No	Unknown	No	Yes	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	High	No	Yes	No	No	No	No	NA			"Discovery,Validation"
PAEFHC	TARGET-20-PAEFHC-09A-02R	Male	White	Not Hispanic or Latino	2558	Relapse	651	Alive	3965	1997	2008	CCG-2961	52.4	85	56	No	No	M2	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[20]"	Yes	0.76	No	No	No	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	High	No	Yes	No	No	No	No	NUP98-NSD1			Other Genomic Analyses
PAEGRE	TARGET-20-PAEGRE-03A-02R	Female	White	Not Hispanic or Latino	5506	Censored	4037	Alive	4037	1997	2008	CCG-2961	21.8	80	69	No	No	M4	No	No	No	No	No	No	No	Yes	No	Yes	No	No	No	Yes	No	No	No	No	 	4	inv(16)	"48,XX,+8,inv(16)(p13q22),+22[4]/48,idem,del(7)(q22q32)[8]/46,XX[8]"	No	NA	Yes	No	No	No	No	No	Unknown	NA	Unknown	NA	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	CBFB-MYH11			Other Genomic Analyses
PAEGRI	TARGET-20-PAEGRI-03A-01R	Male	White	Not Hispanic or Latino	6021	Censored	1867	Alive	1867	1997	2002	CCG-2961	49.7	88	53	No	No	M5	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	Yes	No	No	 	1	MLL	"46,XY,t(9:11)(p22:q23)[36]"	No	NA	No	No	No	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	Unevaluable	Standard	No	Not done	Not done	Not done	Not done	Not done	KMT2A-MLLT3			Other Genomic Analyses
PAEIKD	TARGET-20-PAEIKD-09A-01R	Male	Black or African American	Not Hispanic or Latino	282	Relapse	809	Alive	3600	1998	2008	CCG-2961	13.2	87	0	No	No	M5	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	Yes	No	No	 	1	MLL	"46,XY,t(9:11)(p22:q23)[19]/46,XY[1]"	No	NA	Yes	No	No	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	Standard	No	Yes	No	No	No	No	KMT2A-MLLT3			"Discovery,Validation"
PAEJBT	TARGET-20-PAEJBT-09A-02R	Male	Unknown	Not Hispanic or Latino	3673	Death without Remission	80	Dead	80	1999	1999	CCG-2961	23.8	50	79	No	No	M4	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	No	 	2	t(8;21)	"45,X,-Y,t(8:21)(q22:q22)[19]/46,XY[1]"	No	NA	No	No	No	No	No	No	Unknown	NA	Unknown	NA	CR	Death	Low	No	Not done	Not done	Not done	Not done	Not done	RUNX1-RUNX1T1			Other Genomic Analyses
PAERAH	TARGET-20-PAERAH-09A-03R	Male	White	Not Hispanic or Latino	6366	Relapse	309	Dead	538	1999	2001	CCG-2961	31.1	91	84	No	No	M4	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	t(8;21)	"46,XY,inv(2)(p11.2q13)c,t(8:21)(q22:q22)[20]"	No	NA	No	No	No	No	No	No	Unknown	NA	Unknown	NA	CR	CR	Low	No	Yes	No	Yes	No	Yes	RUNX1-RUNX1T1			"Discovery,Validation"
PAESVN	TARGET-20-PAESVN-09A-02R	Female	Unknown	Hispanic or Latino	3891	Relapse	587	Alive	3280	1999	2008	CCG-2961	10.5	50	7	No	No	M2	No	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	Other	"46,XX,t(3;5)(q2?3:q31)"	No	NA	No	No	No	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	Standard	No	Yes	No	No	No	No	NPM1-MLF1			Other Genomic Analyses
PAKERZ	TARGET-20-PAKERZ-09A-01R	Female	White	Not Hispanic or Latino	1022	Relapse	221	Dead	397	2000	2001	CCG-2961	4.8	89	32	No	No	M1	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	 	0	Unknown	I	No	NA	No	No	No	No	Not done	Not done	Unknown	NA	Unknown	NA	Unevaluable	CR	Unknown	No	Yes	No	No	No	No	NUP98-KDM5A			"Discovery,Validation"
PAKHBF	TARGET-20-PAKHBF-09A-01R	Male	White	Not Hispanic or Latino	816	Relapse	299	Alive	2026	2000	2006	CCG-2961	17.9	42	19	No	Yes	M2	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	 	NA	Unknown	Unknown	No	NA	No	No	Unknown	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	Unknown	No	Yes	No	No	No	No	NA			Other Genomic Analyses
PAKIWK	TARGET-20-PAKIWK-09A-01R	Male	White	Not Hispanic or Latino	1248	Relapse	107	Alive	112	2000	2001	CCG-2961	13.9	14	3	No	No	M6	No	No	No	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	 	2	Other	"46,XY,del(9)(q22q34)[13]/46,idem,add(18)(p13)[4]/46,XY[3]"	No	NA	No	Unknown	No	Unknown	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	Standard	No	Yes	No	No	No	No	NA			"Discovery,Validation"
PAKIYW	TARGET-20-PAKIYW-09A-01R	Female	White	Not Hispanic or Latino	163	Relapse	461	Alive	2965	2000	2008	CCG-2961	136	73	68	No	No	M4	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	Yes	No	No	 	1	MLL	"46,XX,t(9:11)(p22:q23)[15]/46,XX[3]"	No	NA	No	Unknown	No	Unknown	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	Standard	No	Yes	No	No	No	No	KMT2A-MLLT3			Discovery
PAKKBK	TARGET-20-PAKKBK-09A-02R	Female	White	Not Hispanic or Latino	705	Relapse	286	Dead	371	2000	2001	CCG-2961	405.5	90	97	No	No	M1	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	6	Other	"46,XX,+1,der(1:16)(q10:p10),-2,-14,+2mar[19]/46,XX[1]"	Yes	0.54	No	No	No	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	High	Yes	Yes	No	No	No	No	ZEB2-BCL11B			"Discovery,Validation"
PAKLPD	TARGET-20-PAKLPD-09A-02R	Female	White	Not Hispanic or Latino	147	Censored	2707	Alive	2707	2000	2008	CCG-2961	194.4	75	84	Yes	No	M5	No	No	No	No	Yes	No	Yes	No	No	No	No	No	No	No	No	Yes	No	No	 	1	MLL	"46,XX,t(11:19)(q23:p13)[20]"	No	NA	No	No	No	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	Standard	Yes	Not done	Not done	Not done	Not done	Not done	KMT2A-ELL			Other Genomic Analyses
PAKRUP	TARGET-20-PAKRUP-09A-02R	Male	Black or African American	Not Hispanic or Latino	2995	Censored	1787	Alive	1787	2001	2006	CCG-2961	155	62	59	Yes	Yes	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	t(8;21)	"46,XY,t(8:21)(q22:q22)[19]"	No	NA	No	Unknown	No	Unknown	Not done	Not done	Unknown	NA	Unknown	NA	CR	Not in CR	Low	No	Not done	Not done	Not done	Not done	Not done	RUNX1-RUNX1T1			Other Genomic Analyses
PAKSMZ	TARGET-20-PAKSMZ-03A-02R	Male	White	Not Hispanic or Latino	6303	Relapse	1117	Dead	1293	2001	2004	CCG-2961	152.7	72	92	No	No	M2	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	 	0	Unknown	C	Yes	0.65	No	Yes	No	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	High	No	Yes	No	No	No	No	NA			Other Genomic Analyses
PAKTCX	TARGET-20-PAKTCX-09A-02R	Female	White	Not Hispanic or Latino	3262	Relapse	269	Dead	1896	2001	2006	CCG-2961	3.9	40	2	No	No	M4	No	No	No	No	Yes	No	Yes	No	No	No	No	No	No	No	No	Yes	No	No	 	1	MLL	"46,XX,t(11:19)(q23:p13.1)"	No	NA	No	Unknown	No	Unknown	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	Standard	No	Yes	No	No	No	No	KMT2A-ELL			"Discovery,Validation"
PAKVGI	TARGET-20-PAKVGI-09A-01R	Female	White	Not Hispanic or Latino	645	Relapse	665	Dead	1229	2001	2004	CCG-2961	11.3	30	6	No	No	M7	No	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	No	No	No	 	5	Other	"46,XX,t(7:10:16)(p15:q23:p11.2),del(13)(q12q21)[10]/49,idem,+X,+6,+21[8]/46,XX[10]"	No	NA	No	No	No	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	Standard	No	Yes	No	No	No	No	NUP98-KDM5A			Other Genomic Analyses
PAKVYM	TARGET-20-PAKVYM-09A-02R	Male	Black or African American	Not Hispanic or Latino	5797	Relapse	271	Dead	448	2001	2002	CCG-2961	84.8	64	54	No	No	M2	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XY,inv(16)(p13.1q22)[20]"	No	NA	No	No	No	No	No	No	Unknown	NA	Unknown	NA	CR	CR	Low	No	No	Yes	No	No	Yes	CBFB-MYH11			Discovery
PALBYP	TARGET-20-PALBYP-09A-02R	Female	Asian	Not Hispanic or Latino	2145	Censored	2419	Alive	2419	2001	2008	CCG-2961	92.9	95	90	Yes	No	M4	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XX[25]"	No	NA	No	Yes	No	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	Not in CR	Low	No	Not done	Not done	Not done	Not done	Not done	NA			Other Genomic Analyses
PALFVW	TARGET-20-PALFVW-09A-01R	Female	Black or African American	Not Hispanic or Latino	4183	Relapse	385	Dead	451	2001	2003	CCG-2961	31.8	28	26	No	No	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	t(8;21)	"46,XX,t(8:21)(q22:q22)[20]"	No	NA	No	No	No	No	No	No	Unknown	NA	Unknown	NA	CR	CR	Low	No	Yes	No	No	No	No	RUNX1-RUNX1T1			Other Genomic Analyses
PALGKX	TARGET-20-PALGKX-09A-03R	Female	Unknown	Hispanic or Latino	4723	Relapse	214	Dead	485	2001	2003	CCG-2961	69.2	73	83	No	No	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	3	t(8;21)	"46,XX,der(7)t(7:9)(q22:q13),t(8:21)(q22:q22),add(9)(q13)[20]"	No	NA	No	No	No	No	No	Yes	Unknown	NA	Unknown	NA	CR	CR	Low	No	Yes	No	No	No	No	RUNX1-RUNX1T1			"Discovery,Validation"
PALHVV	TARGET-20-PALHVV-09A-02R	Male	White	Not Hispanic or Latino	4837	Relapse	244	Dead	693	2002	2003	CCG-2961	42.8	65	50	No	Yes	M4	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[30]"	No	NA	No	Unknown	No	Unknown	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	Standard	No	Yes	No	No	No	No	NA			Discovery
PALVKV	TARGET-20-PALVKV-09A-02R	Female	White	Not Hispanic or Latino	4902	Relapse	353	Alive	2343	2002	2009	CCG-2961	33.9	40	61	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XX,inv(16)(p13.1q22)[19]"	No	NA	No	Unknown	No	No	Yes	No	Unknown	NA	Unknown	NA	CR	CR	Low	No	Yes	No	No	No	No	CBFB-MYH11			Discovery
PAMVKZ	TARGET-20-PAMVKZ-09A-03R	Male	White	Not Hispanic or Latino	5934	Relapse	517	Dead	693	2004	2005	AAML03P1	248	74	85	Yes	No	M2	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	 	NA	Unknown	Unknown	No	NA	Yes	No	No	No	Not done	Not done	Unknown	NA	No	0	CR	CR	Unknown	No	Yes	No	No	No	No	RUNX1-RUNX1T1	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PAMVVP	TARGET-20-PAMVVP-09A-03R	Male	White	Unknown	3354	Censored	3308	Alive	3308	2004	2013	AAML03P1	16.1	41	39	No	No	M2	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[20]"	No	NA	Yes	Yes	No	No	Not done	Not done	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	NA	Gentuzumab ozogamicin treatment		Other Genomic Analyses
PAMYAS	TARGET-20-PAMYAS-09A-03R	Male	White	Not Hispanic or Latino	3972	Relapse	991	Alive	3263	2004	2013	AAML03P1	5.6	63	18	No	Yes	M2	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Other	"46,XY[20]. nuc ish AML1-ETO positive ~30% of cells consistent with a t(8;21)."	Yes	0.15	No	No	No	No	Not done	Not done	Yes	2	Yes	0.2	Not in CR	CR	Standard	No	Yes	No	No	No	No	RUNX1-RUNX1T1	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PAMYGX	TARGET-20-PAMYGX-09A-03R	Female	White	Not Hispanic or Latino	1259	Censored	3380	Alive	3380	2004	2013	AAML03P1	16	79	31	No	No	M7	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	Other	"46,XX,del(11)(q21q23)[19]/46,XX[1]"	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Not done	Not done	Not done	Not done	Not done	KMT2A-MLLT10	Gentuzumab ozogamicin treatment	no refractory sample sent to BCCA (Primary/Fibroblast pair only)	"Discovery,Validation"
PAMYJX	TARGET-20-PAMYJX-09A-04R	Female	Unknown	Unknown	4607	Relapse	364	Dead	483	2004	2005	AAML03P1	18.4	25	10	No	No	M2	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	Other	"46,XX,t(6;9)(p23;q34)[20]"	No	NA	No	No	No	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	Standard	No	Yes	No	No	No	No	DEK-NUP214	Gentuzumab ozogamicin treatment		Other Genomic Analyses
PANAEV	TARGET-20-PANAEV-09A-03R	Male	White	Not Hispanic or Latino	3539	Censored	2767	Alive	2767	2004	2011	AAML03P1	37.8	59	31.5	No	No	M5	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[24] "	No	NA	Yes	Yes	No	No	Not done	Not done	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	NA	Gentuzumab ozogamicin treatment		Other Genomic Analyses
PANBWF	TARGET-20-PANBWF-09A-03R	Male	White	Not Hispanic or Latino	6219	Censored	2602	Alive	2602	2004	2011	AAML03P1	83.4	77	59	No	No	M4	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[20] "	Yes	0.47	No	Yes	No	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	Unevaluable	High	Yes	Not done	Not done	Not done	Not done	Not done	NA	Gentuzumab ozogamicin treatment		Other Genomic Analyses
PANBYS	TARGET-20-PANBYS-09A-03R	Male	White	Not Hispanic or Latino	4459	Censored	1532	Alive	1532	2004	2008	AAML03P1	162	50	49	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	Yes	No	"der(3)t(3;17)(p25;q21), -17, +Y, +22"	5	inv(16)	"48,XY,+Y,inv(16)(p13.1q22),+22[16]/46,idem,-Y,der(3)t(3;17)(p25;q21),-17[2]/46,XY[2] "	No	NA	Unknown	Unknown	Unknown	Unknown	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	CBFB-MYH11	Gentuzumab ozogamicin treatment		Other Genomic Analyses
PANBZH	TARGET-20-PANBZH-09A-03R	Male	White	Not Hispanic or Latino	3921	Relapse	284	Dead	462	2004	2005	AAML03P1	170	85	89	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	i(17)(q10)	2	inv(16)	"46,XY, inv(16)(p13.1q22),i(17)(q10)[18]  "	No	NA	No	No	No	Yes	No	No	No	0	Unknown	NA	CR	CR	Low	No	No	No	Yes	No	No	CBFB-MYH11	Gentuzumab ozogamicin treatment		Other Genomic Analyses
PANCSC	TARGET-20-PANCSC-09A-03R	Female	White	Not Hispanic or Latino	3890	Relapse	725	Alive	2899	2004	2012	AAML03P1	173		97	No	No	NOS	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XX[20]"	No	NA	No	No	Yes	No	Not done	Not done	No	0	No	0	CR	CR	Low	No	Yes	No	No	No	No	NA	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANDER	TARGET-20-PANDER-09A-02R	Female	White	Not Hispanic or Latino	4312	Relapse	1868	Alive	3291	2004	2013	AAML03P1	137	93.2	88.5	No	No	M1	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	t(8;21)	"46,XX,t(8;21)(q22;q22)[20]"	No	NA	Yes	No	No	No	No	No	Yes	0.1	No	0	CR	CR	Low	No	Yes	No	No	No	No	RUNX1-RUNX1T1	Gentuzumab ozogamicin treatment		Other Genomic Analyses
PANDIX	TARGET-20-PANDIX-09A-03R	Male	White	Not Hispanic or Latino	6573	Relapse	728	Alive	3069	2004	2012	AAML03P1	14.1	40	3	No	No	M2	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[30]"	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Yes	No	No	No	No	NA	Gentuzumab ozogamicin treatment		Induction Failure
PANFMG	TARGET-20-PANFMG-09A-04R	Male	White	Not Hispanic or Latino	1430	Censored	3253	Alive	3253	2004	2013	AAML03P1	65.9	91	84	No	No	M5	No	No	No	No	Yes	No	No	No	No	No	No	No	No	Yes	No	Yes	No	No	 	2	MLL	"47,XY,+8,t(9;11)(p22;q23)[20] "	No	NA	No	No	No	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	Standard	Yes	Not done	Not done	Not done	Not done	Not done	KMT2A-MLLT3	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANGCM	TARGET-20-PANGCM-03A-03R	Male	White	Not Hispanic or Latino	3235	Relapse	496	Alive	3055	2004	2013	AAML03P1	140.9	58	54.5	Yes	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XY,inv(16)(p13.1q22)[13]/46,XY[6] "	No	NA	No	No	No	No	No	No	Yes	2	No	0	CR	CR	Low	No	No	No	No	Yes	No	CBFB-MYH11	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANGDN	TARGET-20-PANGDN-09A-05R	Male	White	Not Hispanic or Latino	6590	Relapse	633	Alive	3063	2004	2013	AAML03P1	176.2	89	38	No	No	M5	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[20]"	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Yes	No	No	No	No	KMT2A-MLLT4	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANGJY	TARGET-20-PANGJY-09A-03R	Female	White	Not Hispanic or Latino	594	Censored	2983	Alive	2983	2004	2012	AAML03P1	302	86	69	No	No	M5	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	der(15)t(1;15)(q12;q26)	1	Other	"46,XX,der(15)t(1;15)(q12;q26)[12] "	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	Yes	Not done	Not done	Not done	Not done	Not done	NA	Gentuzumab ozogamicin treatment		Other Genomic Analyses
PANGTF	TARGET-20-PANGTF-09A-04R	Female	White	Unknown	5814	Relapse	458	Dead	616	2004	2006	AAML03P1	30.8	94.2	11	No	No	M5	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XX[20] "	No	NA	No	No	No	No	Not done	Not done	Unknown	NA	No	0	CR	CR	Standard	No	Yes	No	No	No	No	NUP98-KDM5A	Gentuzumab ozogamicin treatment		Other Genomic Analyses
PANHYK	TARGET-20-PANHYK-09A-01R	Male	White	Not Hispanic or Latino	2191	Censored	1675	Alive	1675	2004	2009	AAML03P1	11.2	71	41	No	No	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	No	#NAME?	2	t(8;21)	"45,X,-Y,t(8;21)(q22;q22)[20]  REPORT ONLY"	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	RUNX1-RUNX1T1	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANINI	TARGET-20-PANINI-09A-03R	Male	White	Hispanic or Latino	6118	Censored	3144	Alive	3144	2004	2013	AAML03P1	16.9	86	87	No	No	NOS	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY"	No	NA	No	No	Yes	No	Not done	Not done	Unknown	NA	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	NA	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANJGR	TARGET-20-PANJGR-09A-03R	Male	White	Hispanic or Latino	4425	Censored	1728	Alive	1728	2004	2009	AAML03P1	14	78.2	75	No	No	NOS	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	t(8;21)	"46,XY,t(8;12;21)(q22;p11.2;q22)[20] "	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	RUNX1-RUNX1T1	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANJVI	TARGET-20-PANJVI-03A-02R	Male	Black or African American	Not Hispanic or Latino	2277	Censored	2131	Alive	2131	2004	2010	AAML03P1	16.4	93	69	No	No	M1	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	"t(2;21)(q11.2;q22), add(16)(p13.3)"	2	Other	"46,XY,t(2;21)(q11.2;q22),add(16)(p13.3)[17]/46,XY[2] "	No	NA	Unknown	Unknown	Unknown	Unknown	Not done	Not done	No	0	No	0	CR	CR	Standard	Yes	Not done	Not done	Not done	Not done	Not done	RUNX1-AFF3	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANKFG	TARGET-20-PANKFG-09A-02R	Male	White	Not Hispanic or Latino	408	Censored	1591	Alive	1591	2004	2009	AAML03P1	42.8	62	49	No	No	M4	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	 	NA	Unknown	Unknown	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Unknown	No	Not done	Not done	Not done	Not done	Not done	KMT2A-MLLT3	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANKFZ	TARGET-20-PANKFZ-09A-04R	Male	White	Not Hispanic or Latino	690	Censored	3116	Alive	3116	2004	2013	AAML03P1	64.1	50	45	No	No	NOS	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	 	NA	Unknown	Unknown	No	NA	Yes	No	No	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	Unknown	No	Not done	Not done	Not done	Not done	Not done	NA	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANKKE	TARGET-20-PANKKE-09A-03R	Male	White	Hispanic or Latino	261	Relapse	269	Alive	3149	2004	2013	AAML03P1	125.9	52	50	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XY,inv(16)(p13.1q22)[18] [report only]"	No	NA	No	No	No	No	Not done	Not done	No	0	Yes	1.8	CR	CR	Low	No	Yes	Yes	No	No	No	CBFB-MYH11	Gentuzumab ozogamicin treatment		Discovery
PANKNB	TARGET-20-PANKNB-09A-03R	Male	Black or African American	Not Hispanic or Latino	6460	Censored	443	Alive	443	2004	2006	AAML03P1	81.5	95.3	84	No	No	M4	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[35] REPORT ONLY"	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Not done	Not done	Not done	Not done	Not done	KMT2A-MLLT3	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANLIR	TARGET-20-PANLIR-09A-02R	Male	Native Hawaiian or other Pacific Islander	Not Hispanic or Latino	5885	Relapse	425	Alive	3238	2005	2013	AAML03P1	45.3	21	33	No	No	M2	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,Xy[20]"	No	NA	No	No	Yes	No	Not done	Not done	Yes	2	No	0	CR	CR	Low	No	Yes	No	No	No	No	NA	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANLIZ	TARGET-20-PANLIZ-09A-03R	Male	Black or African American	Not Hispanic or Latino	3102	Relapse	329	Dead	784	2005	2007	AAML03P1	6.4	90	39	No	No	NOS	No	Yes	No	No	No	No	No	No	No	No	No	No	No	Yes	No	No	No	No	 	2	t(8;21)	"47,XY,+8,t(8;21)(q22;q22)[13]/46,XY[7] "	NO	NA	NO	NO	NO	NO	NO	NO	No	0	Unknown	NA	CR	CR	Low	No	Yes	No	No	No	No	RUNX1-RUNX1T1	Gentuzumab ozogamicin treatment		Discovery
PANLJN	TARGET-20-PANLJN-09A-03R	Male	White	Hispanic or Latino	6524	Censored	2133	Alive	2133	2005	2010	AAML03P1	11.8	88	45	No	No	M1	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[20] "	No	NA	Yes	Yes	No	No	Not done	Not done	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	NA	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANLKB	TARGET-20-PANLKB-09A-03R	Female	White	Not Hispanic or Latino	1678	Censored	1985	Alive	1985	2005	2010	AAML03P1	97.6	74.6	74	No	No	M5	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	add(15)(q26)	1	Other	"46,XX,add(15)(q26)[7]/46,XX[4]  REPORT ONLY "	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Not done	Not done	Not done	Not done	Not done	NA	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANLLX	TARGET-20-PANLLX-09A-01R	Male	Native Hawaiian or other Pacific Islander	Not Hispanic or Latino	4559	Relapse	614	Alive	3234	2005	2013	AAML03P1	2.1	25	0	No	No	M2	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[20]"	No	NA	No	No	No	No	Not done	Not done	Yes	0.8	Unknown	NA	CR	Unevaluable	Standard	No	Yes	No	No	No	No	NA	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANLRE	TARGET-20-PANLRE-09A-05R	Male	White	Hispanic or Latino	3417	Relapse	293	Alive	1831	2005	2010	AAML03P1	13.9	45	30	No	No	M4	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	t(8;21)	"46,XY,t(8;21)(q22;q22)[20] "	No	NA	No	No	No	No	No	No	No	0	No	0	CR	CR	Low	No	Yes	No	Yes	No	No	RUNX1-RUNX1T1	Gentuzumab ozogamicin treatment		Other Genomic Analyses
PANLXK	TARGET-20-PANLXK-09A-03R	Female	Unknown	Not Hispanic or Latino	986	Censored	3095	Alive	3095	2005	2013	AAML03P1	243.3	63	39	No	No	M4	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	 	NA	Unknown	Unknown	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Unknown	No	Not done	Not done	Not done	Not done	Not done	NA	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANLXM	TARGET-20-PANLXM-09A-03R	Female	Asian	Not Hispanic or Latino	3748	Relapse	284	Dead	390	2005	2006	AAML03P1	11.2	54	65	No	No	M2	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XX[20] "	Yes	0.22	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Yes	No	No	No	No	NUP98-HMGB3	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANNHB	TARGET-20-PANNHB-09A-03R	Female	Black or African American	Not Hispanic or Latino	1482	Relapse	366	Dead	436	2005	2006	AAML03P1	19.4	58	63	No	No	M2	No	Yes	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	Yes	#NAME?	3	t(8;21)	"46,XX,del(7)(q32q34),t(8;21)(q22;q22)[17]/45,idem,-X[3] REPORT ONLY"	NO	NA	No	NO	NO	NO	Not done	Not done	Yes	0.9	Yes	1.6	CR	CR	Low	No	Yes	No	No	No	No	RUNX1-RUNX1T1	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANNJI	TARGET-20-PANNJI-09A-03R	Male	Black or African American	Not Hispanic or Latino	5177	Death	95	Dead	95	2005	2005	AAML03P1	37.8	78	88	No	No	M1	No	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	No	No	No	 	1	Other	"47,XY,+21[15]"	No	NA	No	No	Yes	No	Not done	Not done	Yes	0.5	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	NA	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANPKN	TARGET-20-PANPKN-09A-03R	Male	White	Hispanic or Latino	359	Censored	3630	Alive	3630	2005	2015	AAML03P1	120.7	71	63	No	No	M5	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	Yes	No	No	 	1	MLL	"46,XY,t(9;11)(p22;q23)[20]  REPORT ONLY"	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Not done	Not done	Not done	Not done	Not done	KMT2A-MLLT3	Gentuzumab ozogamicin treatment		Discovery
PANPLS	TARGET-20-PANPLS-03A-04R	Female	White	Not Hispanic or Latino	703	Relapse	325	Dead	702	2005	2007	AAML03P1	57.6	44	41	No	No	M2	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	 	NA	Unknown	Unknown	No	NA	No	No	No	No	Not done	Not done	Yes	0.02	No	0	CR	CR	Unknown	No	Yes	No	No	No	No	RUNX1-RUNX1T1	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANPTM	TARGET-20-PANPTM-09A-02R	Male	White	Not Hispanic or Latino	5853	Relapse	342	Alive	3130	2005	2013	AAML03P1	86.7	72	47	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XY,inv(16)(p13.1q22)[20] "	No	NA	No	No	No	No	No	No	No	0	No	0	CR	CR	Low	No	Yes	No	No	No	No	CBFB-MYH11	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANSBH	TARGET-20-PANSBH-09A-05R	Male	White	Hispanic or Latino	491	Relapse	523	Dead	813	2005	2007	AAML03P1	11.5	93	19	No	No	M0	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	ider(16)(q10)del(16)(q22)	1	Other	"46,XY,ider(16)(q10)del(16)(q22)[[30] "	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Yes	No	No	No	No	FUS-FEV	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANSJB	TARGET-20-PANSJB-09A-03R	Male	Unknown	Hispanic or Latino	4074	Relapse	297	Dead	422	2005	2006	AAML03P1	24.3	70	61	No	No	NOS	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[20]"	Yes	0.74	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	High	No	Yes	No	No	No	No	NA	Gentuzumab ozogamicin treatment		Discovery
PANTNA	TARGET-20-PANTNA-09A-02R	Male	White	Not Hispanic or Latino	6416	Relapse	311	Dead	1152	2005	2008	AAML03P1	23.7	65	84	No	No	M2	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	"der(1)t(1;1)(q42;p22),der(1)t(1;1)(p34;q21),t(11;16)(q25;p11.2),del(13)(q12q22)"	4	Other	"46,XY,der(1)t(1;1)(q42;p22),der(1)t(1;1)(p34;q21),t(6;9)(p25;p22)c,t(11;16)(q25;p11.2)[9]/46,idem,del(13)(q12q22)[10]"	No	NA	No	No	No	No	Not done	Not done	Unknown	NA	Yes	0.8	CR	CR	Standard	No	Yes	Yes	No	No	No	FUS-FLI1	Gentuzumab ozogamicin treatment		Other Genomic Analyses
PANTPW	TARGET-20-PANTPW-09A-02R	Female	White	Not Hispanic or Latino	821	Censored	2946	Alive	2946	2005	2013	AAML03P1	152.6	91.5	89	No	No	M1	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XX[20] [REPORT ONLY]"	No	NA	No	No	Yes	No	Not done	Not done	No	0	No	0	CR	CR	Low	Yes	Not done	Not done	Not done	Not done	Not done	CBFA2T3-GLIS2	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANUTB	TARGET-20-PANUTB-09A-05R	Female	White	Not Hispanic or Latino	5587	Relapse	763	Dead	925	2005	2008	AAML03P1	127.8	90	95	No	No	M2	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XX,inv(16)(p13q22)23]/46,XX[2]"	No	NA	No	No	No	No	Yes	No	No	0	No	0	CR	CR	Low	No	Yes	No	No	No	No	CBFB-MYH11	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANUUA	TARGET-20-PANUUA-09A-02R	Female	White	Not Hispanic or Latino	5405	Relapse	462	Dead	1767	2005	2010	AAML03P1	76.6	60	77	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	t(17;19)(q11.2;q13.3)	2	inv(16)	"46,XX,inv(16)(p13.1q22)[16]/46,idem,t(17;19)(q11.2;q13.3)[4]  REPORT ONLY"	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Low	No	Yes	No	No	No	No	CBFB-MYH11	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANVBP	TARGET-20-PANVBP-09A-02R	Female	Unknown	Hispanic or Latino	5749	Death	136	Dead	136	2005	2005	AAML03P1	35.1	93	55	No	No	NOS	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	 	NA	Unknown	Unknown	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Unknown	No	Not done	Not done	Not done	Not done	Not done	NA	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANVGE	TARGET-20-PANVGE-09A-02R	Male	White	Not Hispanic or Latino	5346	Censored	2819	Alive	2819	2005	2013	AAML03P1	54.8	85	70	No	No	NOS	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	22	2	inv(16)	"47,XY,inv(16)(p13.1q22),+22[20] "	No	NA	Yes	No	No	Yes	Not done	Not done	Yes	2	Yes	0.8	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	CBFB-MYH11	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANVGP	TARGET-20-PANVGP-03A-04R	Male	Unknown	Unknown	4950	Relapse	391	Alive	2688	2005	2012	AAML03P1	25.7	72	81	No	No	M4	No	Yes	No	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	del 9q	2	t(8;21)	"46,XY,t(8;20;21)(q22;q13.1;q22),del(9)(q22q34)[20]"	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Low	No	Yes	No	No	No	No	RUNX1-RUNX1T1	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANWHP	TARGET-20-PANWHP-09A-02R	Female	White	Not Hispanic or Latino	1852	Censored	2738	Alive	2738	2005	2013	AAML03P1	77.2	61	59	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XX,inv(16)(p13.1q22)[16]/46,XX[4] "	No	NA	No	No	No	No	No	Yes	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	CBFB-MYH11	Gentuzumab ozogamicin treatment	no refractory sample sent to BCCA (Primary/Fibroblast pair only)	"Discovery,Validation"
PANYGP	TARGET-20-PANYGP-09A-01R	Male	Unknown	Hispanic or Latino	2059	Censored	715	Alive	715	2005	2007	AAML03P1	74.9	67	83	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XY,inv(16)(p13.1q22)[19]/46,XY[1]"	No	NA	Yes	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	CBFB-MYH11	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANYNR	TARGET-20-PANYNR-03A-03R	Male	White	Not Hispanic or Latino	3310	Relapse	321	Alive	2952	2005	2013	AAML03P1	46.2	72	57	No	No	M2	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	Yes	No	"-Y,-7 (side line, no reported as monosomy 7),-9"	5	inv(16)	"46,XY,inv(16)(p13.1q22)[11]/92,idemx2[2]/89,idemx2,-Y,-7,-9[4]/46,XY[4] "	No	NA	No	No	No	No	No	Yes	No	0	No	0	CR	CR	Low	No	Yes	Yes	No	No	No	CBFB-MYH11	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANYSN	TARGET-20-PANYSN-03A-04R	Male	White	Not Hispanic or Latino	6470	Censored	914	Alive	914	2005	2008	AAML03P1	65	80	68	No	No	M1	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	 	NA	Unknown	Unknown	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Unknown	No	Not done	Not done	Not done	Not done	Not done	NA	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANZKA	TARGET-20-PANZKA-09A-02R	Female	White	Not Hispanic or Latino	637	Censored	2824	Alive	2824	2005	2013	AAML03P1	11.1	99	35	No	No	M5	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	Yes	No	No	 	1	MLL	"46,XX,t(9;11)(p22;q23)[22] "	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Not done	Not done	Not done	Not done	Not done	KMT2A-MLLT3	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PANZWB	TARGET-20-PANZWB-09A-02R	Male	White	Not Hispanic or Latino	4932	Censored	2776	Alive	2776	2005	2013	AAML03P1	53.5	67	42	No	No	M4	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	t(8;16)(q22;q22.1)	1	Other	"46,XY,t(8;16)(q22;q22.1)[22]/46,XY[2] "	No	NA	No	No	No	No	Not done	Not done	No	0	Unknown	NA	CR	CR	Standard	Yes	Not done	Not done	Not done	Not done	Not done	CBFB-MYH11	Gentuzumab ozogamicin treatment		Other Genomic Analyses
PAPAEG	TARGET-20-PAPAEG-09A-02R	Male	White	Not Hispanic or Latino	2948	Induction Failure	35	Dead	494	2005	2007	AAML03P1	22.3	73	68	No	No	NOS	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[20] "	Yes	0.55	No	No	No	Yes	Not done	Not done	Yes	0.4	Unknown	NA	Not in CR	Not in CR	High	Unknown	Yes	No	No	No	No	NA	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PAPAWN	TARGET-20-PAPAWN-09A-02R	Male	White	Hispanic or Latino	2154	Censored	2605	Alive	2605	2005	2012	AAML03P1	253.2	71	77	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XY,inv(16)(p13.1q22)[14]/46,XY[16] "	No	NA	NO	NO	NO	NO	NO	NO	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	CBFB-MYH11	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PAPBEJ	TARGET-20-PAPBEJ-09A-03R	Female	Black or African American	Not Hispanic or Latino	367	Relapse	263	Dead	404	2005	2006	AAML03P1	60.3	50	55	No	No	M5	No	No	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	"der(6)t(6;12;7)(p12;p13;p22),der(7)t(6;12;7)del(7)(q11.2),der(12)t(6;12;7),r(9)(p12q12),+19"	4 or more	Other	"47,XX,der(6)t(6;12;7)(p12;p13;p22),der(7)t(6;12;7)del(7)(q11.2),der(12)t(6;12;7),r(9)(p12q12),+19[16]46,idem,-r(9)[3]/46,XX[1] "	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Yes	Yes	No	No	No	NUP98-KDM5A	Gentuzumab ozogamicin treatment		Induction Failure
PAPUNR	TARGET-20-PAPUNR-09A-02R	Female	White	Not Hispanic or Latino	4846	Censored	2083	Alive	2083	2006	2012	AAML0531	18.2	52	30	No	No	M4	No	No	No	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	del(9)(q13q22)	1	Other	"46,XX,del(9)(q13q22)[7]/46,XX[13]"	No	N/A	No	Yes	No	No	Not done	Not done	No	0	Unknown	N/A	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	NA	NO Gentuzumab ozogamicin treatment		"Discovery,Validation"
PAPVCN	TARGET-20-PAPVCN-09A-03R	Male	White	Not Hispanic or Latino	4231	Relapse	486	Alive	2592	2006	2013	AAML0531	62.2	75	51	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XY,inv(16)(p13.1q22)[20]"	No	NA	No	No	No	No	Yes	No	No	0	Unknown	NA	CR	CR	Low	No	Yes	No	No	No	No	CBFB-MYH11	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PAPVDV	TARGET-20-PAPVDV-03A-01R	Male	White	Not Hispanic or Latino	2318	Censored	2688	Alive	2688	2006	2014	AAML0531	11.4	35.6	34	No	No	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	t(8;21)	"46,XY,t(2;21;8)(p21;q22;q22)[20]"	No	NA	No	No	No	No	No	No	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	RUNX1-RUNX1T1	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PAPVGE	TARGET-20-PAPVGE-09A-03R	Male	Black or African American	Not Hispanic or Latino	4807	Relapse	591	Dead	769	2006	2008	AAML0531	13.4	32	38	No	No	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	t(8;21)	"46,XY,t(8;21)(q22;q22)[20]"	No	N/A	No	No	No	No	No	No	Unknown	N/A	Unknown	N/A	CR	CR	Low	No	Yes	No	No	No	No	RUNX1-RUNX1T1	NO Gentuzumab ozogamicin treatment		"Discovery,Validation"
PAPVZK	TARGET-20-PAPVZK-09A-03R	Male	White	Not Hispanic or Latino	5822	Relapse	541	Alive	2492	2006	2013	AAML0531	146	100	66	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XY,inv(16)(p13.1q22)[20]"	No	NA	No	No	No	No	Yes	No	No	0	No	0	CR	CR	Low	No	Yes	No	No	Yes	No	CBFB-MYH11	Gentuzumab ozogamicin treatment		Other Genomic Analyses
PAPWHS	TARGET-20-PAPWHS-09A-03R	Male	White	Not Hispanic or Latino	4852	Censored	2687	Alive	2687	2006	2014	AAML0531	81.2	36	63	No	Yes	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	t(8;21)	"46,XY,t(8;21)(q22;q22)[21]"	No	NA	No	No	No	No	No	No	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	RUNX1-RUNX1T1	NO Gentuzumab ozogamicin treatment		"Discovery,Validation"
PAPWIU	TARGET-20-PAPWIU-09A-03R	Female	American Indian or Alaska Native	Not Hispanic or Latino	4421	Censored	2829	Alive	2829	2006	2014	AAML0531	52.2	75	86	No	No	M1	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XX"	No	NA	No	No	Yes	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	NA	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PAPWYK	TARGET-20-PAPWYK-09A-03R	Female	White	Not Hispanic or Latino	8231	Death	199	Dead	199	2006	2007	AAML0531	66.1	36	36	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XX,inv(16)(p13.1q22)[20]"	No	NA	No	No	No	No	No	No	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	CBFB-MYH11	Gentuzumab ozogamicin treatment		"Validation,TMA"
PAPWZR	TARGET-20-PAPWZR-09A-01R	Female	White	Hispanic or Latino	4936	Induction Failure	68	Dead	483	2006	2008	AAML0531	88.1	71	61	No	No	M5	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	No	Yes	No	No	 	1	MLL	"46,XX,t(6;11)(q27;q23)[20]"	No	N/A	No	No	No	No	Not done	Not done	Yes	0.7	Yes	0.3	Not in CR	Not in CR	Standard	Yes	Yes	No	No	No	No	KMT2A-MLLT4	NO Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PAPXRJ	TARGET-20-PAPXRJ-09A-01R	Female	Black or African American	Not Hispanic or Latino	2855	Relapse	392	Dead	1248	2008	2010	AAML0531	22.9	29	13	No	No	M2	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	idic(9)(q11)	2	Other	"46,XX,t(6;9)(p23;q34)[12]/46,XX,der(6)t(6;9)(p23;q34),idic(9)(q11)[7]/46,XX[1]"	No	NA	No	No	No	No	Not done	Not done	No	0	Unknown	NA	CR	CR	Standard	No	Yes	No	No	No	No	DEK-NUP214	Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PAPXUF	TARGET-20-PAPXUF-09A-01R	Male	White	Not Hispanic or Latino	6436	Induction Failure	79	Alive	1070	2006	2009	AAML0531	62.6	69	57	No	No	M2	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[22]"	Yes	0.34	No	No	No	Yes	Not done	Not done	Yes	41	Yes	8.6	Not in CR	Not in CR	Standard	Unknown	Yes	No	No	No	No	NUP98-NSD1	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PAPXWI	TARGET-20-PAPXWI-09A-03R	Female	White	Not Hispanic or Latino	1430	Relapse	410	Alive	880	2006	2009	AAML0531	128.7	89	74	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XX,inv(16)(p13.1q22)[20]"	No	NA	No	No	No	No	No	Yes	No	0	No	0	CR	CR	Low	No	Yes	Yes	No	Yes	No	CBFB-MYH11	Gentuzumab ozogamicin treatment		"Validation,TMA"
PAPZIZ	TARGET-20-PAPZIZ-09A-03R	Male	White	Not Hispanic or Latino	5611	Relapse	411	Dead	974	2007	2009	AAML0531	54.4	90	76	Yes	No	M5	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	MLL	"46,XY,t(?5;11)(p15;q23)[21]"	No	N/A	No	No	No	No	Not done	Not done	No	0	Unknown	N/A	CR	CR	Standard	No	Yes	No	No	No	No	other MLL	Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PAPZLT	TARGET-20-PAPZLT-09A-02R	Male	Other	Hispanic or Latino	1358	Relapse	506	Dead	803	2007	2009	AAML0531	338.4	87.6	76	No	No	M5	No	No	No	No	Yes	No	No	No	No	No	No	No	Yes	No	No	Yes	No	No	 	2	Other	"46,XY,t(9;11)(p22;q23)[10]/45,idem,-7[10]"	No	N/A	No	No	No	No	Not done	Not done	Yes	0.7	No	0	CR	CR	High	Yes	No	Yes	Yes	No	No	KMT2A-MLLT3	Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PARAJX	TARGET-20-PARAJX-09A-02R	Male	White	Not Hispanic or Latino	618	Censored	2803	Alive	2803	2007	2014	AAML0531	42	70	80	No	No	Unknown	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	"+15, t(20;21)(q11.2;q22)"	2	Other	"47,XY,+15,t(20;21)(q11.2;q22)[19]/46,XY[1]"	No	NA	No	No	No	No	Not done	Not done	No	0.04	No	0	CR	CR	Standard	No	Not done	Not done	Not done	Not done	Not done	RUNX1-CBFA2T2	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PARANT	TARGET-20-PARANT-09A-02R	Male	White	Not Hispanic or Latino	6397	Censored	2509	Alive	2509	2007	2013	AAML0531	5.1	31	40	No	No	M2	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[29]"	No	NA	No	No	No	No	Not done	Not done	Unknown	NA	No	0	CR	CR	Standard	Yes	Not done	Not done	Not done	Not done	Not done	NA	Gentuzumab ozogamicin treatment		"Validation,TMA"
PARASV	TARGET-20-PARASV-03A-03R	Male	White	Not Hispanic or Latino	4401	Relapse	435	Dead	749	2007	2009	AAML0531	26.2	95	67	No	No	M5	No	No	No	No	No	Yes	No	No	No	No	No	No	No	Yes	No	Yes	No	No	 	2	MLL	"47,XY,+8,t(10;11)(p12;q23)[10]"	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	Yes	Yes	No	No	No	No	KMT2A-MLLT10	Gentuzumab ozogamicin treatment		"Validation,TMA"
PARBFJ	TARGET-20-PARBFJ-09A-02R	Male	White	Not Hispanic or Latino	4701	Censored	2387	Alive	2387	2007	2013	AAML0531	46.1	86	57	No	No	M4	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[60]"	No	NA	Yes	Yes	No	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	NA	Gentuzumab ozogamicin treatment		"Validation,TMA"
PARBFZ	TARGET-20-PARBFZ-03A-02R	Female	Unknown	Hispanic or Latino	5298	Censored	2373	Alive	2373	2007	2013	AAML0531	59.3	77	54	Yes	No	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	t(8;21)	"46,XX,t(8;21)(q22;q22)[20]"	No	N/A	No	No	No	No	No	Yes	Yes	0.7	Unknown	N/A	Not in CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	RUNX1-RUNX1T1	Gentuzumab ozogamicin treatment		"Validation,TMA"
PARBIU	TARGET-20-PARBIU-09A-03R	Female	White	Not Hispanic or Latino	5830	Relapse	809	Dead	917	2007	2009	AAML0531	16.5	99	77	No	No	M5	No	No	No	No	Unknown	No	No	No	No	No	No	No	No	No	No	Yes	No	No	 	1	MLL	Inadequate. ish MLL sep	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Yes	No	No	No	No	KMT2A-MLLT3	NO Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PARBRA	TARGET-20-PARBRA-09A-03R	Female	White	Not Hispanic or Latino	2792	Relapse	637	Dead	1362	2007	2010	AAML0531	73.6	78	35	No	No	M5	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	Yes	No	No	 	1	MLL	"46,XX,t(10;11)(p11.2;q23)[20]"	No	NA	No	No	No	No	Not done	Not done	Unknown	NA	No	0	CR	CR	Standard	No	Yes	No	No	Yes	No	KMT2A-MLLT10	Gentuzumab ozogamicin treatment		"Validation,TMA"
PARBTV	TARGET-20-PARBTV-09A-02R	Male	White	Not Hispanic or Latino	6273	Induction Failure	77	Dead	444	2007	2008	AAML0531	247.1	87	95	No	No	M1	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[20]"	No	N/A	No	No	No	No	Not done	Not done	Yes	28	Yes	6.9	Not in CR	Not in CR	Standard	Unknown	Yes	No	No	No	No	NA		EOI I	"This is an AML-IF (induction failure) case that is also included in the AML discovery clinical data, as  'TARGET-21-PARBTV' - Induction Failure,Validation,TMA"
PARBVE	TARGET-20-PARBVE-09A-02R	Male	White	Not Hispanic or Latino	4665	Censored	2820	Alive	2820	2007	2014	AAML0531	18.1	72	58	No	Yes	M4	No	No	No	No	No	No	No	Yes	No	Yes	No	No	No	No	No	No	No	No	 	2	inv(16)	"46,XY,t(16;16)(p13.1;q22)[13]/46,idem,del(7)(q22q32)[7]"	No	N/A	No	No	No	No	No	No	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	CBFB-MYH11	Gentuzumab ozogamicin treatment		"Validation,TMA"
PARBXE	TARGET-20-PARBXE-09A-04R	Female	Unknown	Unknown	447	Relapse	925	Alive	2758	2007	2014	AAML0531	206.3	81	45	No	No	M5	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	"inv(8),t(11;12),del(15q)"	4	MLL	"46,XX,inv(8)(q11.2q24.1),der(11)t(11;12)(q13;q13)t(11;12)(q23;q24.3),der(12)t(11;12)t(11;12),del(15)(q22q24)"	No	NA	No	No	No	No	Not done	Not done	Yes	23	No	0	Not in CR	CR	Standard	No	Yes	No	No	No	No	t(11;12)(q23;q24)	NO Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PARCCH	TARGET-20-PARCCH-03A-03R	Male	White	Hispanic or Latino	339	Relapse	109	Dead	228	2007	2007	AAML0531	208.6		60	No	No	M0	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[20]"	NO	NA	NO	NO	NO	NO	Not done	Not done	Yes	3.7	Yes	5.6	CR	CR	Standard	No	Yes	No	No	No	No	CBFA2T3-GLIS2	Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PARCEV	TARGET-20-PARCEV-09A-02R	Female	White	Not Hispanic or Latino	4152	Relapse	308	Dead	669	2007	2009	AAML0531	111	94	88	No	No	M4	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	No	No	No	No	 	1	Other	"47,XX,+8[12]"	Yes	0.69	No	No	No	Yes	Not done	Not done	Yes	0.5	No	0	CR	CR	High	No	Yes	No	No	No	No	NA	Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PARCHW	TARGET-20-PARCHW-09A-01R	Male	Other	Hispanic or Latino	4209	Relapse	299	Dead	395	2007	2008	AAML0531	76.5	80	43	No	No	Unknown	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XY,inv(16)(p13.1q22)[17]/46,XY[3]"	Yes	0.07	No	No	No	No	Yes	No	Unknown	N/A	Unknown	N/A	Not in CR	CR	Low	No	Yes	No	No	No	No	CBFB-MYH11	NO Gentuzumab ozogamicin treatment		Validation
PARCUK	TARGET-20-PARCUK-09A-03R	Female	White	Not Hispanic or Latino	5987	Relapse	203	Dead	279	2007	2008	AAML0531	23.9	96	63	No	No	M4	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	4	Other	"46,XX,del(10)(q22q24),t(11;11)(p15;q13.1),-16,+mar[16]/46,XX[4],"	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Yes	No	Yes	No	No	NA	Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PARCZL	TARGET-20-PARCZL-09A-02R	Female	White	Hispanic or Latino	3806	Relapse	985	Alive	2695	2007	2014	AAML0531	94.8	50.5	37	Yes	Yes	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	2	t(8;21)	"46,XX,t(15;21)(q22;q22), cryp ins(8;21)(q22;q22q22)[19].ish der(8)ins(8;21)(q22;q22)(ETO+,RUNX1+)"	No	NA	No	No	No	No	No	No	No	0	No	0	Not in CR	CR	Low	No	Yes	No	No	No	No	RUNX1-RUNX1T1	Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PARDDA	TARGET-20-PARDDA-09A-02R	Male	White	Not Hispanic or Latino	4593	Censored	2768	Alive	2768	2007	2014	AAML0531	4.5	88	56	No	No	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	No	#NAME?	2	t(8;21)	"45,X,-Y,t(8;21)(q22;q22)[18]"	No	N/A	No	No	No	No	Yes	No	No	0	No	0	Not in CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	RUNX1-RUNX1T1	Gentuzumab ozogamicin treatment		"Validation,TMA"
PARDDY	TARGET-20-PARDDY-09A-05R	Male	White	Not Hispanic or Latino	677	Relapse	247	Dead	766	2007	2009	AAML0531	115	80	79	No	No	M1	No	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	No	No	No	"5p-, i(7q),14q+,+21"	4	Other	"47,XY,del(5)(p15.1),i(7)(q10),add(14)(q32),+21[21]"	No	NA	No	No	No	No	Not done	Not done	Yes	16	No	0	Not in CR	CR	Standard	No	Yes	No	No	No	No	NA	NO Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PARDMG	TARGET-20-PARDMG-09A-03R	Female	White	Not Hispanic or Latino	6535	Relapse	287	Dead	413	2007	2008	AAML0531	54.8	57	62	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XX,inv(16)(p13.1q22)[20]"	Yes	0.15	No	No	No	No	No	No	No	0	No	0	CR	CR	Low	No	Yes	No	No	No	No	CBFB-MYH11	NO Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PARDZW	TARGET-20-PARDZW-09A-01R	Female	Asian	Not Hispanic or Latino	2808	Censored	2555	Alive	2555	2007	2014	AAML0531	68.3	71	85	No	No	M1	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XX[30]"	Yes	0.69	No	Yes	No	No	Not done	Not done	No	0	Yes	1.5	CR	CR	High	Yes	Not done	Not done	Not done	Not done	Not done	NA	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PAREFM	TARGET-20-PAREFM-09A-02R	Female	White	Not Hispanic or Latino	4353	Censored	837	Alive	837	2007	2009	AAML0531	143	55	90	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XX,inv(16)(p13.1q22)[20]"	No	N/A	No	No	No	No	No	No	Unknown	N/A	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	CBFB-MYH11	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PARENB	TARGET-20-PARENB-09A-03R	Female	Other	Hispanic or Latino	2758	Censored	314	Alive	314	2007	2008	AAML0531	31.7	80	83	No	Unknown	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	 	2	t(8;21)	"45,X,-X,t(8;21)(q22;q22)[20]"	No	NA	No	No	No	No	No	Yes	Yes	3	Yes	1	Not in CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	RUNX1-RUNX1T1	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PARFAL	TARGET-20-PARFAL-09A-05R	Male	White	Not Hispanic or Latino	6922	Relapse	256	Dead	378	2007	2008	AAML0531	11.7	69	43	No	No	Unknown	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	Yes	No	No	 	6	MLL	"47,XY,t(10;11)(p13;q21),+19[2]/46,idem,der(7;11)(q10;q10)[4]/46,idem,psu dic(7;11)(p22;p11.2)[4]/46,idem,der(7;19)(q10;q10),+mar[4]/46,XY[5]"	No	NA	No	No	No	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	Standard	No	Yes	No	No	No	No	MLLT10-PICALM	NO Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PARGTL	TARGET-20-PARGTL-09A-02R	Female	White	Not Hispanic or Latino	5787	Censored	1515	Alive	1515	2007	2011	AAML0531	18.5	72	72	No	No	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	#NAME?	2	t(8;21)	"45,X,-X,t(8;21)(q22;q22)[18]/46,XY[2]"	No	N/A	No	No	No	No	No	No	No	0	No	0	Not in CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	RUNX1-RUNX1T1	NO Gentuzumab ozogamicin treatment		Validation
PARGVC	TARGET-20-PARGVC-03A-03R	Male	White	Hispanic or Latino	1802	Relapse	230	Dead	295	2007	2008	AAML0531	58	86	81	Yes	No	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	No	#NAME?	4	t(8;21)	"45,X,-Y,t(8;21)(q22;q22),add(13)(p11.2),add(22)(p11.2)"	No	NA	No	No	No	No	No	No	No	0	Unknown	NA	CR	CR	Low	No	Yes	No	No	No	No	RUNX1-RUNX1T1	Gentuzumab ozogamicin treatment		Validation
PARHBA	TARGET-20-PARHBA-03A-02R	Female	Unknown	Unknown	6879	Censored	1105	Alive	1105	2007	2010	AAML0531	68.2	98	85	No	No	M1	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XX[26]"	Yes	0.23	Yes	Yes	No	No	Not done	Not done	No	0	No	0	Not in CR	CR	Low	Yes	Not done	Not done	Not done	Not done	Not done	NA	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PARHJV	TARGET-20-PARHJV-09A-01R	Male	White	Not Hispanic or Latino	939	Censored	2662	Alive	2662	2007	2014	AAML0531	12.8	95	39	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	add(11)(p11.2)	2	inv(16)	"46,XY,add(11)(p11.2),inv(16)(p13.1q22)[17]/46,XY[3]"	No	N/A	No	No	No	No	No	No	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	CBFB-MYH11	Gentuzumab ozogamicin treatment		"Validation,TMA"
PARHVI	TARGET-20-PARHVI-03A-03R	Male	White	Not Hispanic or Latino	6006	Censored	1167	Alive	1167	2007	2010	AAML0531	432	72	92	No	Yes	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	2	inv(16)	"46,XY,der(2)t(2;16)(p11.2;q22),der(16)inv(16)(p13q22)t(2;16)(p11.2;q22)[20]"	No	N/A	No	No	No	No	No	No	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	CBFB-MYH11	Gentuzumab ozogamicin treatment		"Validation,TMA"
PARHVK	TARGET-20-PARHVK-09A-04R	Female	White	Not Hispanic or Latino	4983	Relapse	376	Alive	2516	2007	2014	AAML0531	24.2	92	93	No	No	M1	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	No	Yes	No	No	 	1	MLL	"46,XX,ins(6;11)(q27;q22q23.3)[17]/46,XX[3]"	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Yes	No	No	No	No	KMT2A-MLLT4	NO Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PARIHK	TARGET-20-PARIHK-03A-03R	Male	White	Not Hispanic or Latino	3830	Induction Failure	77	Dead	923	2007	2010	AAML0531	20.2	46	52	No	No	NOS	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	No	No	No	No	 	1	Other	"47,XY,+8[8]/46,XY[16]"	Yes	0.62	No	No	No	No	Not done	Not done	No	0	No	0	CR	Not in CR	High	No	Yes	No	No	No	No	NA	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PARIMT	TARGET-20-PARIMT-03A-01R	Female	White	Not Hispanic or Latino	2748	Relapse	383	Alive	2476	2007	2014	AAML0531	34.9	44	41	No	No	M4	No	No	No	No	No	No	No	Yes	No	Yes	No	No	No	No	No	No	No	No	 	2	inv(16)	"46,XX,inv(16)(p13.1q22)[19]/46,idem,del(7)(q22)[1]"	No	NA	No	No	No	No	No	Yes	No	0	No	0	Not in CR	CR	Low	No	Yes	No	No	No	No	CBFB-MYH11	Gentuzumab ozogamicin treatment		"Validation,TMA"
PARIZR	TARGET-20-PARIZR-03A-02R	Male	Black or African American	Hispanic or Latino	2695	Censored	2457	Alive	2457	2007	2014	AAML0531	7.4	70	35	No	Yes	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	No	#NAME?	2	t(8;21)	"45,X,-Y,ins(21;8)(q22.1;q13q22.1)[20]"	No	NA	No	No	No	No	No	No	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	RUNX1-RUNX1T1	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PARJCR	TARGET-20-PARJCR-09A-01R	Male	Unknown	Unknown	5348	Relapse	318	Dead	468	2007	2008	AAML0531	1.3	86.2	12	No	No	M5	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	No	No	 	1	MLL	"46,XX,cryp add(11)(q23). ish MLL sep (del 3'MLL)"	No	NA	No	No	No	No	Not done	Not done	Yes	4.1	Yes	0.1	CR	CR	Standard	No	Yes	No	No	No	No	KMT2A-MLLT4	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PARJWH	TARGET-20-PARJWH-09A-01R	Male	White	Hispanic or Latino	349	Induction Failure	76	Dead	162	2007	2008	AAML0531	10.8	85	3	No	No	M5	No	No	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	 	5	Other	"46,XY,del(1)(p36.1),der(7)r(7)(p22q36)dup(7)(q11.2q22),t(8;22)(p11.2;q13)[17]/47,idem,+i(8)(q10)[2]"	No	N/A	Yes	No	No	No	Not done	Not done	Yes	0.1	No	0.02	CR	Not in CR	Standard	No	Yes	No	No	No	No	KAT6A-EP300	Gentuzumab ozogamicin treatment		"This is an AML-IF (induction failure) case that is also included in the AML discovery clinical data, as  'TARGET-21-PARHRS' - Induction Failure,Validation,TMA"
PARJYP	TARGET-20-PARJYP-03A-01R	Female	Other	Not Hispanic or Latino	5433	Censored	1798	Alive	1798	2007	2012	AAML0531	122.5	80	56	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XX,inv(16)(p13.1q22)"	No	NA	No	No	No	No	No	Yes	Unknown	NA	No	0	Not in CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	CBFB-MYH11	Gentuzumab ozogamicin treatment		Validation
PARKCX	TARGET-20-PARKCX-09A-03R	Female	White	Not Hispanic or Latino	292	Censored	2760	Alive	2760	2007	2015	AAML0531	382.5	92	92	No	No	M5	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	Yes	No	No	 	1	MLL	"46,XX,t(9;11)(p22;q23)[20]"	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Not done	Not done	Not done	Not done	Not done	KMT2A-MLLT3	Gentuzumab ozogamicin treatment		Validation
PARKFB	TARGET-20-PARKFB-09A-02R	Male	White	Not Hispanic or Latino	6631	Relapse	600	Alive	2162	2007	2013	AAML0531	58.6	87.5	92	No	Yes	M5	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	No	No	+4 in Clone 2	3	MLL	"46,XY,derI10)t(10;21;11)(p12;q22;q23)inv(11)(q13q23),der(11)t(11;21)(q13;q22),der(21)t(10;21)(p12;q22)[3]/47,idem,+4[17]"	No	N/A	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Yes	No	No	No	No	KMT2A-MLLT10	Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PARLMY	TARGET-20-PARLMY-09A-01R	Female	White	Hispanic or Latino	2904	Relapse	308	Dead	565	2007	2009	AAML0531	50.1	61	55	No	No	Unknown	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	6	2	t(8;21)	"46,XX,t(8;21)(q22;q22)[13]/47,idem,+6[7]"	No	N/A	No	No	No	No	No	Yes	No	0	No	0	CR	CR	Low	No	Yes	No	No	No	No	RUNX1-RUNX1T1	NO Gentuzumab ozogamicin treatment		"Discovery,Validation"
PARLSW	TARGET-20-PARLSW-09A-02R	Female	White	Hispanic or Latino	4906	Censored	2613	Alive	2613	2007	2014	AAML0531	61.1	80	36	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XX,inv(16)(p13.1q22)[20]"	No	N/A	No	No	No	No	No	No	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	CBFB-MYH11	NO Gentuzumab ozogamicin treatment		Validation
PARMME	TARGET-20-PARMME-09A-02R	Female	White	Not Hispanic or Latino	3832	Censored	2363	Alive	2363	2007	2014	AAML0531	17.5	90	61	No	No	M1	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XX[20]"	Yes	0.49	No	Yes	No	No	Not done	Not done	Yes	2	Unknown	N/A	CR	CR	High	No	Not done	Not done	Not done	Not done	Not done	NA	Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PARMZC	TARGET-20-PARMZC-09A-02R	Male	White	Not Hispanic or Latino	6006	Censored	828	Alive	828	2007	2010	AAML0531	125.9	68	78	No	Yes	M2	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[20]"	Yes	0.09	No	No	Yes	No	Not done	Not done	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	NA	Gentuzumab ozogamicin treatment		Validation
PARMZF	TARGET-20-PARMZF-09A-02R	Female	White	Not Hispanic or Latino	3163	Relapse	294	Alive	2193	2007	2013	AAML0531	200.1	90	62	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XX,inv(16)(p13.1q22)[20]"	No	NA	No	No	No	No	Yes	No	No	0	No	0	CR	CR	Low	No	Yes	No	No	No	No	CBFB-MYH11	NO Gentuzumab ozogamicin treatment		Validation
PARPBF	TARGET-20-PARPBF-09A-02R	Male	White	Not Hispanic or Latino	6424	Death without Remission	84	Dead	84	2007	2008	AAML0531	20	60	82	No	No	Unknown	No	No	No	No	No	No	No	No	No	No	Yes	No	No	Yes	No	No	No	No	del(9)	3	Other	"46,XY,add(2)(q35)[5]/46,sl,del(9)(q12q32)[3]/47,sdl1,+8[12]"	No	N/A	No	No	No	No	Not done	Not done	No	0	Unknown	N/A	CR	Death	Standard	No	Not done	Not done	Not done	Not done	Not done	FUS-FEV	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PARPDS	TARGET-20-PARPDS-09A-01R	Female	White	Not Hispanic or Latino	3774	Relapse	550	Dead	836	2007	2010	AAML0531	2.1	70	9	No	No	Unknown	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	No	No	No	No	"+X,+10,+19,+21,dup(12q)"	More than 6	Other	"48,XX,+X,+8[3]/51,XX,+X,+X,+10,dup(12)(q13q15),+19,+21[2]/46,XX[3] "	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Yes	No	No	No	No	NA	Gentuzumab ozogamicin treatment		Validation
PARPVZ	TARGET-20-PARPVZ-09A-02R	Female	White	Not Hispanic or Latino	4155	Relapse	611	Dead	1377	2007	2011	AAML0531	156	51	76	No	No	M2	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	Other	"46,XX,t(6;9)(p23;q34)[20]"	Yes	0.44	No	No	No	No	Not done	Not done	No	0	Unknown	N/A	CR	CR	High	Yes	No	Yes	Yes	No	No	DEK-NUP214	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PARPWL	TARGET-20-PARPWL-09A-03R	Male	Black or African American	Not Hispanic or Latino	766	Censored	1199	Alive	1199	2007	2011	AAML0531	134.5	77	40	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	Yes	No	No	No	No	22	3	inv(16)	"47,XY,inv(16)(p13.1q22),+22[13]/48,idem,+8[2] "	No	NA	No	No	No	No	No	No	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	CBFB-MYH11	Gentuzumab ozogamicin treatment		"Validation,TMA"
PARSAN	TARGET-20-PARSAN-03A-01R	Male	White	Hispanic or Latino	5420	Relapse	339	Dead	870	2007	2010	AAML0531	5.3	46	64	No	No	Unknown	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	Other	"46,XY,9ph,t(16;17)(p13.1;p13.3)                                                                                                                "	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Yes	No	No	No	No	NUP98-PHF23	NO Gentuzumab ozogamicin treatment		Validation
PARSHM	TARGET-20-PARSHM-03A-02R	Female	White	Not Hispanic or Latino	358	Relapse	404	Alive	2450	2007	2014	AAML0531	34.8	23	17	No	No	Unknown	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XX,inv(16)(p13.1q22)[22] "	No	NA	No	No	No	No	No	No	Yes	0.1	No	0	CR	CR	Low	No	Yes	No	No	No	No	CBFB-MYH11	NO Gentuzumab ozogamicin treatment		Validation
PARTAL	TARGET-20-PARTAL-09A-02R	Female	White	Not Hispanic or Latino	6000	Relapse	384	Dead	531	2008	2009	AAML0531	70.5	66	16	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XX,inv(16)(p13.1q22)[20]"	No	NA	No	No	No	No	No	No	No	0	No	0	CR	CR	Low	No	Yes	No	No	Yes	No	CBFB-MYH11	NO Gentuzumab ozogamicin treatment		"This case is also found in the AML validation clinical data for frequency testing (TCS) - Induction Failure,Validation,TMA"
PARTST	TARGET-20-PARTST-09A-02R	Male	White	Not Hispanic or Latino	1234	Censored	2379	Alive	2379	2008	2014	AAML0531	123.4	56	77	Yes	Yes	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	Yes	No	No	No	No	 	2	t(8;21)	"46,XY,t(8;21)(q22;q22)[3]/47,idem,+8[18] "	No	N/A	No	No	No	No	No	No	Unknown	N/A	Yes	1.4	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	RUNX1-RUNX1T1	NO Gentuzumab ozogamicin treatment		Validation
PARTXH	TARGET-20-PARTXH-09A-02R	Male	White	Hispanic or Latino	3386	Censored	2330	Alive	2330	2008	2014	AAML0531	192.9	52	69	No	No	M2	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	Other	"46,XY,del(6)(q15q22)[4]/46,XY[17]"	No	N/A	No	No	Yes	No	Not done	Not done	Yes	12	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	NA	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PARTYV	TARGET-20-PARTYV-09A-03R	Male	White	Hispanic or Latino	1636	Censored	406	Alive	406	2008	2009	AAML0531	93.9	80	64	No	No	M1	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[20]"	Yes	0.75	No	No	Yes	Yes	Not done	Not done	No	0	No	0	CR	CR	High	No	Not done	Not done	Not done	Not done	Not done	NUP98-PHF23	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PARUBT	TARGET-20-PARUBT-09A-02R	Female	White	Not Hispanic or Latino	2692	Relapse	293	Dead	586	2008	2009	AAML0531	7.7	96	0	No	No	Unknown	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XX[20]"	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Yes	No	No	No	No	NA	Gentuzumab ozogamicin treatment		"This is an AML-IF (induction failure) case that is also included in the AML discovery clinical data, as  'TARGET-21-PARNAW' - Induction Failure,Validation,TMA"
PARUDL	TARGET-20-PARUDL-03A-01R	Male	White	Not Hispanic or Latino	6446	Relapse	257	Alive	2411	2008	2014	AAML0531	100.7	63	42	No	No	Unknown	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XY,inv(16)(p13.1q22)[25] "	No	NA	No	No	No	No	No	No	No	0	No	0	CR	CR	Low	No	No	Yes	No	No	No	CBFB-MYH11	NO Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PARUNX	TARGET-20-PARUNX-09A-04R	Female	White	Not Hispanic or Latino	2321	Relapse	690	Alive	2364	2008	2014	AAML0531	14.9	87	82	No	No	M1	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	"der(6)t(1;6)(q21;q27),t(7;12)(q36;p13),+19"	3	Other	"48,XX,+der(6)t(1;6)(q21;q27),t(7;12)(q36;p13),+19[18] [t(7;12) nuc ish ETV6 sep] "	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Yes	No	No	No	No	MNX1-ETV6	Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PARURW	TARGET-20-PARURW-09A-02R	Male	Other	Hispanic or Latino	3853	Censored	2283	Alive	2283	2008	2014	AAML0531	11.8	42.5	55	No	No	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	t(8;21)	"46,XY,t(8;21)(q22;q22)[20]"	No	N/A	No	No	No	No	No	No	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	RUNX1-RUNX1T1	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PARUTH	TARGET-20-PARUTH-09A-04R	Male	White	Not Hispanic or Latino	3454	Relapse	488	Dead	1412	2008	2011	AAML0531	42.5	61	71	Yes	Yes	Unknown	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[20].nuc ish CBFBx3[22%]"	No	NA	Yes	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Yes	No	No	No	No	NA	Gentuzumab ozogamicin treatment		"Validation,TMA"
PARUUB	TARGET-20-PARUUB-09A-02R	Female	White	Not Hispanic or Latino	6315	Censored	1882	Alive	1882	2008	2013	AAML0531	31	99	62	No	No	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	#NAME?	2	t(8;21)	"45,X,-X,t(8;21)(q22;q22)[20] "	No	NA	No	No	No	No	No	No	No	0	Unknown	NA	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	RUNX1-RUNX1T1	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PARUWX	TARGET-20-PARUWX-09A-02R	Male	White	Not Hispanic or Latino	1049	Relapse	228	Dead	439	2008	2009	AAML0531	112.5	90	65	No	No	M1	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	No	No	No	No	 	1	Other	"47,XY,+8[5]/46,XY[23]"	Yes	0.54	No	No	No	Yes	Not done	Not done	Yes	3	Yes	0.1	CR	CR	High	Yes	Yes	Yes	No	No	No	NA	Gentuzumab ozogamicin treatment		"Validation,TMA"
PARVAI	TARGET-20-PARVAI-03A-02R	Female	White	Not Hispanic or Latino	6102	Relapse	335	Dead	429	2008	2009	AAML0531	51.1	71	51	No	No	M2	No	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	t(3;5)(q25;q34)	1	Other	"46,XX,t(3;5)(q25;q35)[23] "	Yes	0.22	No	No	No	Yes	Not done	Not done	Unknown	NA	Yes	1	CR	CR	Standard	No	Yes	No	No	No	No	NPM1-MLF1	Gentuzumab ozogamicin treatment		"Validation,TMA"
PARVSF	TARGET-20-PARVSF-09A-02R	Male	White	Not Hispanic or Latino	2330	Relapse	221	Alive	2192	2008	2014	AAML0531	86.9	46.5	18.5	No	No	M6	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[20] "	No	N/A	No	No	No	Yes	Not done	Not done	Unknown	N/A	No	0	CR	CR	Standard	No	Yes	No	No	Yes	No	NUP98-NSD1	Gentuzumab ozogamicin treatment		"Validation,TMA"
PARVUA	TARGET-20-PARVUA-03A-02R	Male	White	Hispanic or Latino	5786	Induction Failure	75	Dead	222	2008	2008	AAML0531	212.5	94	86	No	No	Unknown	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	No	No	No	No	 	1	Other	"47,XY,+8[12]"	Yes	2.67	No	No	No	No	Not done	Not done	Yes	4.9	Unknown	NA	CR	Not in CR	High	No	Yes	No	No	No	No	NA	NO Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PARWDZ	TARGET-20-PARWDZ-09A-01R	Female	White	Not Hispanic or Latino	4855	Relapse	261	Dead	321	2008	2009	AAML0531	137	76.5	91	No	No	M5	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	Yes	No	No	der(1;5)(q10;p10)	2	MLL	"47,XX,+der(1;5)(q10;p10),t(9;11)(p22;q23)[20] "	No	NA	No	No	No	No	Not done	Not done	Unknown	NA	No	0	CR	CR	Standard	No	Yes	No	No	No	No	KMT2A-MLLT3	Gentuzumab ozogamicin treatment		Validation
PARWXU	TARGET-20-PARWXU-09A-02R	Male	Unknown	Not Hispanic or Latino	557	Relapse	439	Alive	2309	2008	2014	AAML0531	246.6		91	No	No	Unknown	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	del(11)(p11.2p15)	1	Other	"46,XY,del(11)(p11.2p15)[15]/46,XY[5] "	No	NA	No	No	No	No	Not done	Not done	No	0	Unknown	NA	CR	CR	Standard	No	Yes	No	No	No	No	NA	Gentuzumab ozogamicin treatment		Validation
PARXBT	TARGET-20-PARXBT-09A-02R	Male	White	Not Hispanic or Latino	3381	Censored	2246	Alive	2246	2008	2014	AAML0531	34.9	68	68	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XY,inv(16)(p13.1q22)[20] "	No	N/A	No	No	No	No	No	No	No	0	No	0	Not in CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	CBFB-MYH11	NO Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PARXMP	TARGET-20-PARXMP-09A-02R	Male	White	Not Hispanic or Latino	534	Censored	1903	Alive	1903	2008	2013	AAML0531	8.7	35	3	No	No	M6	No	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	No	No	No	21	5	Other	"48,XY,der(3)t(3;13)(p24;q14),+6,der(6)t(3;6)(p23;q23)x2,der(13)t(6;13)(q 23;q12),+21[6]/46,XY[14]"	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Not done	Not done	Not done	Not done	Not done	NUP98-KDM5A	Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PARXNG	TARGET-20-PARXNG-09A-01R	Male	Black or African American	Not Hispanic or Latino	3687	Censored	2246	Alive	2246	2008	2014	AAML0531	137	62.5	95	No	No	M2	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[21]"	No	NA	No	No	Yes	No	Not done	Not done	Unknown	NA	Unknown	NA	CR	CR	Low	Yes	Not done	Not done	Not done	Not done	Not done	NA	NO Gentuzumab ozogamicin treatment		"Discovery,Validation"
PARXZP	TARGET-20-PARXZP-09A-01R	Female	White	Not Hispanic or Latino	6657	Relapse	128	Dead	1754	2008	2013	AAML0531	2.6	89.8	16	No	Yes	M5	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	Yes	No	No	add(16)(q24)	2	MLL	"46,XX,der(10)t(10;11)(p12;q23)inv(11)(q13q23),der(11)t(10;11)(p12;q13),add(16 )(q24)[20]  "	No	NA	No	No	No	No	Not done	Not done	No	0	Unknown	NA	CR	CR	Standard	No	Yes	Yes	No	No	No	KMT2A-MLLT10	Gentuzumab ozogamicin treatment		"Validation,TMA"
PARYFN	TARGET-20-PARYFN-03A-01R	Female	White	Not Hispanic or Latino	1597	Relapse	655	Alive	2203	2008	2014	AAML0531	87.8	90	67.9	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XX,inv(16)(p13.1q22)[2] "	No	NA	No	No	No	No	Yes	No	Yes	0.3	No	0	CR	CR	Low	No	Yes	No	No	Yes	No	CBFB-MYH11	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PARYGA	TARGET-20-PARYGA-09A-03R	Male	White	Not Hispanic or Latino	5916	Censored	2406	Alive	2406	2008	2014	AAML0531	59.8	62.3	70	No	No	M4	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[20]"	No	NA	No	No	No	No	Not done	Not done	Unknown	NA	No	0	CR	CR	Standard	Yes	Not done	Not done	Not done	Not done	Not done	NUP98-HMGB3	Gentuzumab ozogamicin treatment		"Validation,TMA"
PARYVW	TARGET-20-PARYVW-09A-01R	Female	White	Hispanic or Latino	664	Relapse	348	Alive	2317	2008	2014	AAML0531	19.4	83	27.4	No	No	NOS	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	t(2;12)(q33;p13)	4	Other	"90,XXXX,t(2;12)(q33;p13)x2,-15,-18[28]"	No	NA	No	No	No	No	Not done	Not done	Yes	0.1	Yes	0.1	Not in CR	CR	Standard	No	Yes	No	No	Yes	No	ETV6-INO8D	NO Gentuzumab ozogamicin treatment		Induction Failure
PARZUU	TARGET-20-PARZUU-09A-04R	Male	White	Not Hispanic or Latino	3273	Relapse	558	Alive	2168	2008	2014	AAML0531	113	95	78	No	No	M1	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	t(8;21)	"46,XY,t(8;21)(q22;q22)[20]"	No	NA	No	No	No	No	Yes	Yes	Yes	2.7	Unknown	NA	CR	CR	Low	No	Yes	No	No	No	No	RUNX1-RUNX1T1	NO Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PARZWH	TARGET-20-PARZWH-09A-03R	Male	White	Hispanic or Latino	4243	Censored	2151	Alive	2151	2008	2014	AAML0531	29.5	92	97	No	No	M1	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[55]"	No	NA	No	No	Yes	No	Not done	Not done	Yes	10	No	0	CR	CR	Low	Yes	Not done	Not done	Not done	Not done	Not done	NA	NO Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PASBHI	TARGET-20-PASBHI-09A-01R	Male	White	Not Hispanic or Latino	2201	Censored	2342	Alive	2342	2008	2014	AAML0531	49.5	92	80	No	No	M1	No	Yes	No	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	del(9)(q13q22)	2	t(8;21)	"46,XY,t(8;21)(q22;q22),del(9)(q13q22)[20] "	No	NA	No	No	No	No	No	No	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	RUNX1-RUNX1T1	Gentuzumab ozogamicin treatment		"Discovery, Validation"
PASBPK	TARGET-20-PASBPK-09A-02R	Male	Black or African American	Not Hispanic or Latino	161	Relapse	239	Alive	2117	2008	2014	AAML0531	162.9	90	70.6	No	Yes	M5	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	19	1	Other	"47,XY,+19[23]   "	No	NA	No	No	No	No	Not done	Not done	No	0	Unknown	NA	Not in CR	CR	Standard	No	Yes	Yes	Yes	No	Yes	NA	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PASBPW	TARGET-20-PASBPW-09A-02R	Male	Asian	Not Hispanic or Latino	5215	Relapse	428	Alive	428	2008	2009	AAML0531	2	80	84	No	No	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	t(8;21)	"46,XY,t(8;21)(q22;q22)[20] "	No	N/A	No	No	No	No	No	No	No	0.03	No	0	CR	CR	Low	No	Yes	No	Yes	No	No	RUNX1-RUNX1T1	NO Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PASBSB	TARGET-20-PASBSB-03A-01R	Female	White	Not Hispanic or Latino	6241	Death	162	Dead	162	2008	2008	AAML0531	165.4		80	No	Yes	M5	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	 	N/A	Unknown	Unknown	Yes	2.2	No	Yes	No	No	Not done	Not done	No	0	No	0	CR	CR	High	Yes	Not done	Not done	Not done	Not done	Not done	NA	Gentuzumab ozogamicin treatment		Other Genomic Analyses
PASCCS	TARGET-20-PASCCS-09A-01R	Male	White	Not Hispanic or Latino	4357	Relapse	763	Alive	2221	2008	2014	AAML0531	6.6	90	76	No	No	M1	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[40] "	No	NA	No	Yes	No	No	Not done	Not done	Yes	2.2	No	0	CR	CR	Low	No	Yes	No	No	No	No	NA	NO Gentuzumab ozogamicin treatment		"Discovery,Validation"
PASCFW	TARGET-20-PASCFW-09A-01R	Female	Asian	Not Hispanic or Latino	733	Censored	2205	Alive	2205	2008	2014	AAML0531	19.1	53	34	No	No	M7	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	No	No	No	No	"+7,+10,der(17)(q21;p13),+19"	5	Other	"50,XX,+7,+8,+10,der(17)t(2;17)(q21;p13),+19[14]/46,XX[11] "	No	NA	No	Unknown	Unknown	Unknown	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Not done	Not done	Not done	Not done	Not done	NA	NO Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PASCGR	TARGET-20-PASCGR-03A-02R	Female	White	Hispanic or Latino	6660	Relapse	255	Dead	702	2008	2010	AAML0531	5.2	31	0	No	Yes	M5	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	"del(10p),add(12p),t(11q;12q)"	4	MLL	"46,XX,del(10)(p13),der(11)t(11;12)(q13;q24.1),der(12)t(11;12)(q13;q24.1)inv(11)(q23q13)/46,idem,add(12)(p11.2) "	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	Not in CR	CR	Standard	No	Yes	Yes	No	No	No	KMT2A-MLLT10	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PASDGX	TARGET-20-PASDGX-09A-02R	Male	White	Not Hispanic or Latino	5973	Censored	1771	Alive	1771	2008	2013	AAML0531	75.2	95	60	No	Yes	M5	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	No	Yes	No	No	"t(1;12)(p36.1;q13),add(4)(q25),t(7;20)(q22;q13)"	4	MLL	"46,XY,t(1;12)(p36.1;q13),add(4)(q25),t(6;11)(q27;q23),t(7;20)(q22;q13)[21]/46,XY[1]"	No	N/A	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Not done	Not done	Not done	Not done	Not done	KMT2A-MLLT4	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PASECW	TARGET-20-PASECW-09A-04R	Male	Black or African American	Not Hispanic or Latino	834	Relapse	259	Dead	330	2008	2009	AAML0531	6.8	72	22	Yes	No	Unknown	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[20] "	NO	N/A	NO	NO	NO	NO	Not done	Not done	Yes	4.8	Unknown	N/A	Not in CR	CR	Standard	No	Yes	No	No	No	No	CBFA2T3-GLIS2	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PASEFD	TARGET-20-PASEFD-09A-01R	Male	White	Not Hispanic or Latino	1373	Relapse	272	Dead	511	2008	2010	AAML0531	8	64	54	No	No	M5	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	der(2)t(2;10)(p13;p12)	2	MLL	"46,XY,der(2)t(2;10)(p13;p12),der(10)t(2;10)(p13;p12)ins(10;11)(p12;q23q13),del(11)(q13q23)[15]/46,XY[15] "	No	N/A	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Yes	No	No	No	No	KMT2A-MLLT10	Gentuzumab ozogamicin treatment		Validation
PASEGC	TARGET-20-PASEGC-09A-01R	Female	White	Not Hispanic or Latino	4312	Censored	2013	Alive	2013	2008	2014	AAML0531	72.3	92	95	No	No	M1	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XX[20] "	Yes	0.35	No	Yes	No	No	Not done	Not done	No	0	Unknown	N/A	CR	CR	Low	Yes	Not done	Not done	Not done	Not done	Not done	NA	Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PASFEW	TARGET-20-PASFEW-09A-05R	Female	White	Unknown	428	Relapse	216	Dead	313	2008	2009	AAML0531	18.6	89	7	No	No	M7	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	Other	"46,XX,add(22)(q13.3)[18]/46,XX[2]"	No	NA	No	No	No	No	Not done	Not done	Yes	0.1	Yes	0.8	CR	CR	Standard	No	Yes	No	No	Yes	No	CBFA2T3-GLIS2	NO Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PASFJB	TARGET-20-PASFJB-03A-01R	Male	White	Not Hispanic or Latino	4151	Relapse	296	Dead	595	2008	2010	AAML0531	133.7	92	81	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XY,inv(16)(p13.1q22)[29]"	NO	NA	NO	NO	NO	NO	NO	YES	Unknown	NA	Unknown	NA	CR	CR	Low	No	Yes	No	No	No	No	CBFB-MYH11	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PASFLM	TARGET-20-PASFLM-09A-01R	Male	White	Not Hispanic or Latino	5140	Relapse	771	Alive	2034	2008	2014	AAML0531	0.9	40.6	16	No	No	NOS	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[59]"	Yes	0.81	No	No	No	No	Not done	Not done	No	0	Unknown	N/A	CR	CR	High	No	Yes	No	No	No	No	NA	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PASFNP	TARGET-20-PASFNP-09A-02R	Male	White	Not Hispanic or Latino	1935	Censored	2206	Alive	2206	2008	2014	AAML0531	26.5	91	59	No	No	M5	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	MLL	"46,XY,inv(11)(p14q23)[16]/46,XY[4] "	No	N/A	No	No	No	No	Not done	Not done	No	0	Unknown	N/A	CR	CR	Standard	No	Not done	Not done	Not done	Not done	Not done	KMT2A-MLLT10	NO Gentuzumab ozogamicin treatment		Validation
PASGGK	TARGET-20-PASGGK-03A-01R	Female	Black or African American	Not Hispanic or Latino	4458	Relapse	777	Alive	2025	2008	2014	AAML0531	4.2	96	22	No	Yes	M5	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	No	Yes	No	No	 	1	MLL	"46,XX,t(6;11;10)(q27;q23;p12)[19]/46,XX[1]"	No	NA	No	No	No	No	Not done	Not done	No	0.02	No	0.03	CR	CR	Standard	No	Yes	No	No	No	No	KMT2A-MLLT10	Gentuzumab ozogamicin treatment		Validation
PASGMZ	TARGET-20-PASGMZ-09A-01R	Female	White	Not Hispanic or Latino	5129	Relapse	267	Dead	789	2008	2010	AAML0531	1.5	64	44	No	No	M1	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XX[20]"	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Yes	No	No	No	No	NA	Gentuzumab ozogamicin treatment		"Validation,TMA"
PASGWH	TARGET-20-PASGWH-09A-04R	Male	White	Not Hispanic or Latino	5251	Relapse	409	Dead	1214	2008	2012	AAML0531	14.2	35.4	61	No	No	M2	No	No	No	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	deletion 9q	1	Other	"46,XY,del(9)(q13q22)[16]/46,XY[4]"	No	NA	No	No	No	No	Not done	Not done	No	0	No	0.02	CR	CR	Standard	No	Yes	No	No	No	Yes	NUP98-NSD1	NO Gentuzumab ozogamicin treatment		"This is an AML-IF (induction failure) case that is also included in the AML discovery clinical data, as  'TARGET-21-PASDXR' - Induction Failure,Validation,TMA"
PASHBI	TARGET-20-PASHBI-09A-01R	Male	White	Not Hispanic or Latino	5727	Censored	1335	Alive	1335	2008	2012	AAML0531	5.6	78	65	No	No	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	No	#NAME?	2	t(8;21)	"45,X,-Y,t(8;21)(q22;q22)[19] "	No	NA	No	No	No	Yes	No	No	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	RUNX1-RUNX1T1	Gentuzumab ozogamicin treatment		"Validation,TMA"
PASHWN	TARGET-20-PASHWN-09A-01R	Female	White	Not Hispanic or Latino	2606	Relapse	243	Dead	373	2008	2009	AAML0531	66.4	50	22	No	No	Unknown	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XX[20]"	Yes	0.14	No	No	No	No	Not done	Not done	No	0	Unknown	N/A	CR	CR	Standard	Yes	Yes	No	No	No	No	NA	NO Gentuzumab ozogamicin treatment		"Discovery,Validation"
PASHYZ	TARGET-20-PASHYZ-09A-03R	Female	White	Not Hispanic or Latino	1695	Relapse	300	Dead	433	2008	2010	AAML0531	30.3	37.8	66	No	No	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	#NAME?	2	t(8;21)	"45,X,-X,t(8;21)(q22;q22)[20]"	No	NA	No	No	No	No	No	Yes	No	0.03	No	0	CR	CR	Low	No	Yes	No	No	No	No	RUNX1-RUNX1T1	NO Gentuzumab ozogamicin treatment		"Induction Failure, TMA"
PASIBG	TARGET-20-PASIBG-09A-01R	Male	White	Hispanic or Latino	748	Relapse	287	Dead	1094	2008	2011	AAML0531	55.3	73.2	85	No	No	M4	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	"t(7;12)(q36;p13),+19"	2	Other	"47,XY,t(7;12)(q36;p13),+19[20]"	No	NA	No	No	No	No	Not done	Not done	Yes	3.6	No	0	CR	CR	Standard	Yes	Yes	No	No	No	No	MNX1-ETV6	NO Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PASIEJ	TARGET-20-PASIEJ-09A-01R	Female	Asian	Not Hispanic or Latino	2686	Relapse	419	Dead	1118	2008	2011	AAML0531	5.4	30	19.1	No	No	M2	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XX[20]"	Yes	0.54	No	No	No	No	Not done	Not done	Yes	2.7	Yes	0.9	CR	CR	High	No	Yes	No	No	No	No	CBFA2T3-GLIS2	Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PASIZX	TARGET-20-PASIZX-09A-01R	Female	White	Not Hispanic or Latino	2275	Censored	2024	Alive	2024	2008	2014	AAML0531	32.1	91	85	No	No	M1	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XX[30]"	Yes	1.21	No	No	No	No	Not done	Not done	Yes	2.1	No	0	CR	CR	High	Yes	Not done	Not done	Not done	Not done	Not done	NA	Gentuzumab ozogamicin treatment		Validation
PASJEJ	TARGET-20-PASJEJ-09A-02R	Male	White	Not Hispanic or Latino	6335	Censored	1980	Alive	1980	2008	2014	AAML0531	33.5	56	73	Yes	Yes	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	No	"-Y, dup(2q)"	3	t(8;21)	"45,X,-Y,add(2)(q34),t(8;21)(q22;q22)[20] "	No	N/A	No	No	No	No	No	No	Yes	16	No	0	Not in CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	RUNX1-RUNX1T1	NO Gentuzumab ozogamicin treatment		"Discovery,Validation"
PASJTM	TARGET-20-PASJTM-09A-01R	Male	Other	Not Hispanic or Latino	901	Censored	1953	Alive	1953	2008	2014	AAML0531	18.2	39	52	No	No	M7	No	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	"t(3;21)(q25;q22.3),r(7)(::p22->q36::?p15->?p22::),der(11)(11pter->11q13::11q24->11q22::7p15->7pter)"	4	Other	"46,XY,t(3;21)(q25;q22.3),del(5)(q31),r(7)(::p22->q36::?p15->?p22::),der(11)(11pter->11q13::11q24->11q22::7p15->7pter) "	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	High	Yes	Not done	Not done	Not done	Not done	Not done	NA	NO Gentuzumab ozogamicin treatment		"Discovery,Validation"
PASKGH	TARGET-20-PASKGH-09A-01R	Male	White	Not Hispanic or Latino	3791	Relapse	308	Alive	478	2009	2010	AAML0531	210	64	20	No	No	M4	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[20] "	Yes	0.47	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	High	Yes	Yes	No	No	No	No	NUP98-NSD1	Gentuzumab ozogamicin treatment		Validation
PASLDL	TARGET-20-PASLDL-09A-02R	Female	White	Not Hispanic or Latino	2964	Censored	2035	Alive	2035	2009	2014	AAML0531	17.3	70	70	No	No	M1	No	Yes	No	No	No	No	No	No	No	No	No	No	No	Yes	No	No	No	Yes	 	3	t(8;21)	"46,X,-X,+8,t(8;21)(q22;q22)[20]"	No	N/A	No	No	No	No	Yes	No	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	RUNX1-RUNX1T1	Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PASLSD	TARGET-20-PASLSD-03A-01R	Female	White	Hispanic or Latino	969	Relapse	251	Alive	2126	2009	2014	AAML0531	59.2	85.8	76	No	No	M5	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	Yes	No	No	 	1	MLL	"46,XX,t(9;11)(p22;q23)[14]/46,XX[6]"	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Yes	No	Yes	Yes	No	KMT2A-MLLT3	Gentuzumab ozogamicin treatment		"Validation,TMA"
PASLTF	TARGET-20-PASLTF-09A-02R	Male	White	Hispanic or Latino	6157	Censored	1891	Alive	1891	2009	2014	AAML0531	49.2	81	67	No	No	Unknown	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[20]"	No	N/A	No	No	Yes	No	Not done	Not done	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	NA	Gentuzumab ozogamicin treatment		"Validation,TMA"
PASLYX	TARGET-20-PASLYX-09A-02R	Female	White	Hispanic or Latino	5392	Relapse	199	Dead	334	2009	2010	AAML0531	58.2	76	44	No	No	M4	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XX[20]"	Yes	1.96	No	Yes	No	No	Not done	Not done	No	0	No	0	Unevaluable	CR	High	Yes	Yes	No	No	No	No	NA	NO Gentuzumab ozogamicin treatment		"Discovery,Validation"
PASMGW	TARGET-20-PASMGW-09A-01R	Male	White	Not Hispanic or Latino	3089	Relapse	237	Dead	286	2009	2009	AAML0531	23.5	85	51	No	No	M5	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	Yes	No	No	 	1	MLL	"46,XY,t(10;11)(p12;q23)[25]"	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	Not in CR	CR	Standard	No	No	No	No	No	Yes	KMT2A-MLLT10	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PASMHY	TARGET-20-PASMHY-03A-03R	Male	White	Not Hispanic or Latino	6979	Relapse	570	Dead	592	2009	2010	AAML0531	94.5	83	91	No	No	M4	No	No	No	No	No	No	No	Yes	No	Yes	No	No	No	No	No	No	No	No	 	2	inv(16)	"46,XY,inv(16)(p13.1q22)[5]/46,idem,del(7)(q22q34)[5] "	No	NA	No	No	No	No	No	Yes	No	0	No	0	CR	CR	Low	No	Yes	No	No	No	No	CBFB-MYH11	Gentuzumab ozogamicin treatment		"Validation,TMA"
PASNIY	TARGET-20-PASNIY-09A-02R	Female	White	Hispanic or Latino	932	Censored	1962	Alive	1962	2009	2014	AAML0531	212.9	55	57	No	No	M5	No	No	No	No	Yes	No	No	No	No	No	No	No	No	Yes	No	Yes	No	No	 	3	MLL	"48,XX,t(5;9;11;9)(q11.2;p22;q23;q22),+der(5)(t(5;9;11;9),+8[20] "	No	N/A	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Not done	Not done	Not done	Not done	Not done	KMT2A-MLLT3	NO Gentuzumab ozogamicin treatment		Validation
PASPFE	TARGET-20-PASPFE-09A-01R	Male	Unknown	Not Hispanic or Latino	462	Relapse	386	Alive	2093	2009	2014	AAML0531	74.3	93.3	44	No	No	M5	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	Yes	No	No	 	1	MLL	"46,XY,t(9;11)(p22;q23)[20] "	No	N/A	Yes	No	No	No	Not done	Not done	Unknown	N/A	No	0	CR	CR	Standard	No	Yes	Yes	Yes	No	No	KMT2A-MLLT3	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PASPGA	TARGET-20-PASPGA-09A-02R	Female	White	Not Hispanic or Latino	1189	Relapse	1093	Dead	1729	2009	2013	AAML0531	35.8	96	95	No	No	M1	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XX[20]"	No	NA	No	Yes	No	No	Not done	Not done	Yes	1.2	No	0	CR	CR	Low	No	Yes	No	No	No	No	NA	Gentuzumab ozogamicin treatment		"Validation,TMA"
PASPKE	TARGET-20-PASPKE-09A-04R	Female	Black or African American	Not Hispanic or Latino	3200	Censored	2026	Alive	2026	2009	2014	AAML0531	11.9	73	58	Yes	No	M4	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	t(8;21)	"46,XX,t(5;21;8)(q31;q22;q22)[20] "	No	NA	No	No	No	No	Yes	No	Unknown	NA	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	RUNX1-RUNX1T1	Gentuzumab ozogamicin treatment		"Validation,TMA"
PASPLU	TARGET-20-PASPLU-09A-02R	Male	White	Not Hispanic or Latino	3399	Induction Failure	86	Dead	351	2009	2010	AAML0531	446	92.6	93	Yes	No	M4	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[20]"	Yes	0.52	No	No	No	Yes	Not done	Not done	No	0	Yes	57	CR	Not in CR	High	No	Yes	No	No	Yes	No	NUP98-NSD1	Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PASPSV	TARGET-20-PASPSV-09A-02R	Female	White	Not Hispanic or Latino	4757	Censored	1880	Alive	1880	2009	2014	AAML0531	10.2	82	46	No	No	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	#NAME?	2	t(8;21)	"46,XX,t(8;21)(q22;q22)[1]/45,idem,-X[18]/46,XX[1] "	No	N/A	No	No	No	No	No	No	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	RUNX1-RUNX1T1	NO Gentuzumab ozogamicin treatment		"Discovery,Validation"
PASPTM	TARGET-20-PASPTM-09A-03R	Female	Asian	Not Hispanic or Latino	5122	Censored	1900	Alive	1900	2009	2014	AAML0531	60.6	70	77	No	No	M2	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XX[20]"	No	NA	No	No	Yes	No	Not done	Not done	Unknown	NA	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	NA	Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PASPTW	TARGET-20-PASPTW-09A-02R	Female	Black or African American	Not Hispanic or Latino	2516	Censored	2062	Alive	2062	2009	2014	AAML0531	21.5	74	84	No	No	M2	No	Yes	No	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	Yes	"-X, 9q-"	3	t(8;21)	"45,X,-X,t(8;21)(q22;q22),del(9)(q13q22)[20] "	NO	NA	NO	NO	NO	NO	YES	NO	Unknown	NA	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	RUNX1-RUNX1T1	NO Gentuzumab ozogamicin treatment		"This case is also found in the AML validation clinical data for frequency testing (TCS) - Induction Failure,Validation"
PASPWZ	TARGET-20-PASPWZ-03A-01R	Female	White	Hispanic or Latino	10	Relapse	113	Dead	175	2009	2009	AAML0531	191.9	50	60	No	Yes	Unknown	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	"t(8;22)(p11.2;q13.3),inv(7)(q11.2q22)"	2	Other	"46,XX,inv(7)(q11.2q22),t(8;22)(p11.2;q13.3)[20]/46,XXc "	No	N/A	No	No	No	No	Not done	Not done	Unknown	N/A	No	0	CR	CR	Standard	No	Yes	No	No	No	No	KAT6A-EP300	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PASREH	TARGET-20-PASREH-09A-02R	Male	White	Hispanic or Latino	2608	Censored	1883	Alive	1883	2009	2014	AAML0531	42.4	68	87.3	No	No	M1	No	Yes	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	 	2	t(8;21)	"46,XY,t(8;21)(q22;q22)[10]/46,idem,add(7)(q31)[10]"	No	N/A	No	No	No	No	No	No	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	RUNX1-RUNX1T1	Gentuzumab ozogamicin treatment		Validation
PASRRB	TARGET-20-PASRRB-03A-01R	Male	White	Not Hispanic or Latino	4465	Censored	1842	Alive	1842	2009	2014	AAML0531	280.8	95	94	No	No	Unknown	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	No	No	No	No	 	1	Other	"47,XY,+8[8]/46,XY[3] "	Yes	0.63	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	High	Yes	Not done	Not done	Not done	Not done	Not done	NUP98-NSD1	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PASRTP	TARGET-20-PASRTP-09A-01R	Female	Other	Unknown	5389	Relapse	234	Alive	2047	2009	2014	AAML0531	237.1	87	93.5	No	Yes	M1	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XX[21] "	Yes	0.73	No	Yes	No	No	Not done	Not done	No	0	Yes	1	Not in CR	CR	High	Yes	Yes	No	No	No	No	NA	NO Gentuzumab ozogamicin treatment		"Discovery,Validation"
PASSSI	TARGET-20-PASSSI-09A-02R	Male	Native Hawaiian or other Pacific Islander	Hispanic or Latino	530	Relapse	462	Dead	712	2009	2011	AAML0531	198.8	91	78	No	Yes	M5	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	MLL	"46,XY,cryp ins(10;11)(p12;q23q23)  "	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Yes	Yes	No	No	No	KMT2A-MLLT10	Gentuzumab ozogamicin treatment		"Validation,TMA"
PASSWG	TARGET-20-PASSWG-03A-01R	Female	Unknown	Unknown	113	Relapse	88	Dead	220	2009	2009	AAML0531	32.7		97	No	Yes	M5	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	No	No	 	2	MLL	"46,XX,der(10)ins(10;11)(p12;q23q23),der(11)t(11;14)(q23;q32.3)del(11)(q23q23),der(14)t(11;14)(q23;q32.3)[18]/46,XX[2]  [cryptic MLL split, IGH split] "	No	N/A	No	No	No	No	Not done	Not done	Yes	1.8	No	0	Not in CR	CR	Standard	No	Yes	No	No	Yes	No	KMT2A-CEP170B	NO Gentuzumab ozogamicin treatment		Validation
PASTPU	TARGET-20-PASTPU-09A-01R	Female	White	Not Hispanic or Latino	5917	Censored	1972	Alive	1972	2009	2014	AAML0531	6.2	65	47	No	No	M2	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XX[20]"	No	N/A	No	No	Yes	No	Not done	Not done	No	0	No	0	CR	CR	Low	No	Not done	Not done	Not done	Not done	Not done	NA	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PASTTW	TARGET-20-PASTTW-09A-01R	Female	Unknown	Not Hispanic or Latino	757	Relapse	475	Dead	600	2009	2011	AAML0531	31.1	93	0	No	No	M7	No	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	No	No	No	21	1	Other	"46,XX,+21[15]/46,XX[5] "	No	NA	No	No	No	No	Not done	Not done	Yes	0.1	Yes	0.1	CR	Unevaluable	Standard	No	Yes	No	No	No	No	CBFA2T3-GLIS2	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PASTUH	TARGET-20-PASTUH-03A-01R	Female	White	Not Hispanic or Latino	5305	Relapse	118	Dead	166	2009	2009	AAML0531	33.5	81.6	46	No	No	M4	No	No	No	No	No	No	Yes	No	No	No	No	No	No	Yes	No	Yes	No	Yes	 	3	MLL	"46,XX,t(11;19)(q23;p13.1)[15]/46,idem,-X,+8[3]/46,XX[2]"	No	NA	No	No	No	No	Not done	Not done	Yes	2.1	Yes	1	CR	CR	Standard	No	Yes	No	No	No	No	KMT2A-ELL	Gentuzumab ozogamicin treatment	EOI I	"This is an AML-IF (induction failure) case that is also included in the AML discovery clinical data, as  'TARGET-21-PASLZE' - Induction Failure,Validation"
PASUHK	TARGET-20-PASUHK-09A-01R	Female	White	Hispanic or Latino	549	Relapse	220	Dead	245	2009	2010	AAML0531	14.8	27	1.7	No	No	M5	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	4	Other	"45,XX,dic(4;20)(q12;q11.2),der(7)(t(1;7)(q25;p22),t(8;16)(q13;q11.2),der(14)(4qter->4q12::20q11.2->20q?13.3::14p12->14qter)[14]/46,XX[6]"	No	N/A	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	Yes	Yes	No	Yes	No	No	NA	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PASVVS	TARGET-20-PASVVS-09A-03R	Male	White	Not Hispanic or Latino	283	Relapse	519	Alive	1968	2009	2014	AAML0531	169	88	55	No	No	M5	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	ins(11q23 into 20p)	4	MLL	"46,Y,der(X)t(X;11)(q24;q23),der(11)(11pter->11q21::11q23->11q23::Xq24->Xqter),inv(12)(p13q13),ins(20;11)(p11.2;q23q21)[16]/47,idem,+2[3]/46,XY[1] "	No	NA	No	No	No	No	Not done	Not done	No	0	Yes	14	Not in CR	CR	Standard	No	No	No	No	Yes	No	KMT2A-SEPT6	Gentuzumab ozogamicin treatment	EOI II	"Discovery,Validation,TMA"
PASVYA	TARGET-20-PASVYA-09A-01R	Male	White	Hispanic or Latino	590	Relapse	291	Dead	630	2009	2011	AAML0531	16.4	49	0	No	No	M7	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[20] "	No	NA	No	No	No	No	Not done	Not done	No	0.02	No	0.03	CR	CR	Standard	No	Yes	No	No	Yes	No	CBFA2T3-GLIS2	Gentuzumab ozogamicin treatment		"Validation,TMA"
PASVYL	TARGET-20-PASVYL-09A-01R	Male	White	Not Hispanic or Latino	6090	Relapse	206	Dead	286	2009	2010	AAML0531	43	80	90	No	No	M5	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	Yes	No	No	 	1	MLL	"46,XY,t(11;19)(q23;p13.3)[20] "	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	No	Yes	Yes	No	No	KMT2A-MLLT1	NO Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PASWAJ	TARGET-20-PASWAJ-09A-04R	Female	White	Not Hispanic or Latino	3298	Relapse	422	Alive	1712	2009	2014	AAML0531	86.6	95	89	No	No	M1	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	MLL	"46,XX,cryp ins(11;6)(q23;q27q27)  "	No	NA	No	No	No	No	Not done	Not done	No	0	Unknown	NA	CR	CR	Standard	No	Yes	No	No	No	No	KMT2A-MLLT4	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PASWAT	TARGET-20-PASWAT-09A-01R	Female	White	Not Hispanic or Latino	5157	Relapse	286	Dead	342	2009	2010	AAML0531	49.5	54	40	No	No	M4	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XX[30]"	No	NA	No	No	No	No	Not done	Not done	Yes	5.3	Yes	2.2	CR	CR	Standard	No	Yes	No	No	No	No	KMT2A-SEPT6	Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PASWLN	TARGET-20-PASWLN-09A-01R	Female	White	Not Hispanic or Latino	6631	Relapse	513	Dead	614	2009	2011	AAML0531	32.4	96	86	No	No	M0	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	Yes	No	No	 	1	MLL	"46,XX,t(9;11)(p22;q23)[20]"	No	NA	No	No	No	No	Not done	Not done	Yes	15	No	0	Not in CR	CR	Standard	No	Yes	No	No	No	Yes	KMT2A-MLLT3	NO Gentuzumab ozogamicin treatment		Validation
PASWPD	TARGET-20-PASWPD-09A-02R	Male	Other	Hispanic or Latino	1454	Relapse	357	Dead	689	2009	2011	AAML0531	2		4	No	No	NOS	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	 	NA	Unknown	Unknown	No	NA	No	No	No	No	Not done	Not done	No	0	Unknown	NA	CR	CR	Unknown	No	Yes	No	No	No	No	NA	Gentuzumab ozogamicin treatment		Validation
PASWPT	TARGET-20-PASWPT-09A-01R	Male	Other	Hispanic or Latino	3438	Relapse	395	Dead	518	2009	2010	AAML0531	44.2	72	74	No	No	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	No	 	3	t(8;21)	"45,X,-Y,t(8;21)(q22;q22)[9}/46,idem,+4[11]"	No	NA	No	No	No	No	No	Yes	Unknown	NA	No	0	CR	CR	Low	No	No	Yes	Yes	No	No	RUNX1-RUNX1T1	NO Gentuzumab ozogamicin treatment		Validation
PASWTY	TARGET-20-PASWTY-09A-01R	Female	White	Not Hispanic or Latino	5109	Relapse	345	Alive	1713	2009	2014	AAML0531	9.4	92	68	No	No	Unknown	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	Yes	No	No	 	1	MLL	"46,XX,t(9;11)(p22;q23)[17]/46,XX[9]"	No	N/A	No	No	No	No	Not done	Not done	Unknown	N/A	Unknown	N/A	CR	CR	Standard	No	Yes	No	No	No	No	KMT2A-MLLT3	NO Gentuzumab ozogamicin treatment		Discovery
PASXVC	TARGET-20-PASXVC-09A-01R	Male	Black or African American	Hispanic or Latino	7442	Relapse	461	Dead	518	2009	2011	AAML0531	41.1	71	15	No	No	M5	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	0	Normal	"46,XY[20]"	Yes	0.37	No	Yes	No	No	Not done	Not done	No	0	No	0	CR	CR	Low	Yes	Yes	No	No	Yes	No	NA	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PASXYG	TARGET-20-PASXYG-09A-05R	Female	White	Hispanic or Latino	4103	Relapse	250	Dead	570	2009	2011	AAML0531	40.5	63.5	68	No	Yes	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	#NAME?	2	t(8;21)	"46,XX,t(8;21)(q22;q22)[5]/45,idem,-X[15]"	No	NA	Yes	No	No	No	No	No	No	0	No	0	Not in CR	CR	Low	No	Yes	No	No	Yes	No	RUNX1-RUNX1T1	Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PASYJI	TARGET-20-PASYJI-09A-03R	Female	White	Not Hispanic or Latino	4545	Relapse	289	Alive	1780	2009	2014	AAML0531	31.1	63	56	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XX,inv(16)(p13.1q22)[18]/46,XX[2]"	No	NA	No	No	No	No	Yes	No	No	0	No	0	CR	CR	Low	No	Yes	No	No	Yes	No	CBFB-MYH11	NO Gentuzumab ozogamicin treatment		"Discovery,Validation"
PASZLJ	TARGET-20-PASZLJ-09A-01R	Female	White	Not Hispanic or Latino	3543	Relapse	127	Dead	289	2009	2010	AAML0531	24.2	95	77	No	No	M5	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	"add(2)(q37),-10,dup(7)(p15p22)"	6	MLL	"45,XX,add(2)(q37),-10,der(11)del(11)(q13q22)trp(11)(q23q23) t(10;11)(q11.2;q23)[14]/45,idem,-der(2),dup(7)(p15p22)[4]/46,XX[2]  "	No	NA	No	No	No	No	Not done	Not done	Yes	0.1	No	0.05	CR	CR	Standard	No	No	No	No	Yes	No	KMT2A-MLLT10	Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PATAST	TARGET-20-PATAST-09A-01R	Male	White	Not Hispanic or Latino	5926	Relapse	289	Dead	1146	2009	2012	AAML0531	31.6	72	49	Yes	Yes	M2	No	Yes	No	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	No	#NAME?	2	t(8;21)	"46,XY,t(8;15;21)(q22;q21;q22)[16]/45,X,idem,-Y[4] "	No	NA	Yes	No	No	No	No	No	No	0	No	0	CR	CR	Low	No	Yes	No	No	No	No	RUNX1-RUNX1T1	Gentuzumab ozogamicin treatment		"Discovery,Validation"
PATBFL	TARGET-20-PATBFL-09A-01R	Male	White	Not Hispanic or Latino	4050	Relapse	128	Alive	1675	2009	2014	AAML0531	218.7	95	92	No	No	M5	No	No	No	No	No	No	No	No	No	No	No	No	No	Yes	No	No	No	No	 	1	Other	"47,XY,+8[30]"	Yes	0.4	No	No	No	No	Not done	Not done	Yes	0.1	No	0	Not in CR	CR	Standard	No	Yes	No	No	Yes	No	NUP98-NSD1	Gentuzumab ozogamicin treatment		"Validation,TMA"
PATDHA	TARGET-20-PATDHA-09A-01R	Female	White	Hispanic or Latino	5544	Relapse	194	Dead	403	2009	2011	AAML0531	1.6	86	21	Yes	No	M2	No	Yes	No	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	del(9)(q12q22)	2	t(8;21)	"46,XX,t(8;21)(q22;q22)[18]/46,idem,del(9)(q12q22)[2] "	No	NA	No	No	No	No	No	No	No	0	No	0	Not in CR	CR	Low	No	Yes	No	No	No	No	RUNX1-RUNX1T1	Gentuzumab ozogamicin treatment		"Validation,TMA"
PATDNN	TARGET-20-PATDNN-09A-03R	Male	White	Hispanic or Latino	1262	Relapse	102	Dead	194	2009	2010	AAML0531	210.9	89	94	No	No	M5	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	Yes	No	No	 	3	MLL	"46,XY,t(9;11)(p22;q23)[8}/48,idem,+2mar[12]"	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Yes	No	No	No	No	KMT2A-MLLT3	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PATELT	TARGET-20-PATELT-03A-05R	Female	White	Not Hispanic or Latino	4401	Censored	1652	Alive	1652	2010	2014	AAML0531	46.7	80	84	No	No	M1	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	Other	"46,XX,t(2;11)(q31;p15)[20]"	No	NA	No	No	No	No	Not done	Not done	Yes	13	Unknown	NA	Not in CR	Unevaluable	Standard	Unknown	Not done	Not done	Not done	Not done	Not done	NUP98-HOXD13	NO Gentuzumab ozogamicin treatment		"Validation,TMA"
PATFDF	TARGET-20-PATFDF-09A-01R	Male	White	Not Hispanic or Latino	866	Relapse	382	Dead	854	2010	2012	AAML0531	332	25	53.3	No	No	NOS	No	No	No	No	Unknown	No	No	No	No	No	No	No	No	No	No	Yes	No	No	 	1	MLL	Inadequate. ish MLL sep	No	N/A	No	No	No	No	Not done	Not done	No	0	Unknown	N/A	CR	CR	Standard	No	Yes	No	No	No	No	other MLL	Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PATGAN	TARGET-20-PATGAN-03A-01R	Male	White	Not Hispanic or Latino	277	Relapse	91	Dead	195	2010	2010	AAML0531	12	25	0	No	Yes	M2	No	No	No	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	"del(9p), +10"	2	Other	"47,XY,del(9)(p22),+10[3]/46,XY[17]  "	No	N/A	No	No	No	No	Not done	Not done	Unknown	N/A	Unknown	N/A	Not in CR	CR	Standard	No	Yes	No	No	No	No	CBFA2T3-GLIS2	NO Gentuzumab ozogamicin treatment		"Discovery,Validation,TMA"
PATIAK	TARGET-20-PATIAK-09A-01R	Female	Black or African American	Not Hispanic or Latino	227	Relapse	277	Alive	1464	2010	2014	AAML0531	45.8	62	59	No	No	M4	No	No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	 	1	inv(16)	"46,XX,inv(16)(p13.1q22)[17]/46,XX[3]"	No	NA	Yes	No	No	No	Yes	No	No	0	No	0	CR	CR	Low	No	Yes	No	No	No	No	CBFB-MYH11	NO Gentuzumab ozogamicin treatment	EOI I	"Discovery,Validation,TMA"
PATJHJ	TARGET-20-PATJHJ-09A-01R	Female	Black or African American	Not Hispanic or Latino	137	Relapse	252	Dead	607	2010	2011	AAML0531	519		90	No	No	M5	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	 	1	MLL	"46,XX,t(4;11)(q21;q23)[14]/46,XX[6]"	No	NA	No	No	No	No	Not done	Not done	No	0	No	0	CR	CR	Standard	No	Yes	Yes	No	Yes	No	KMT2A-AFF1	NO Gentuzumab ozogamicin treatment	EOI I	"This case is also found in the AML validation clinical data for frequency testing (TCS) - Induction Failure,Validation,TMA"
